Sentence,class,file
"http://dx.doi.org/10.1128/MCB.20.4.1149-   1161.200 0 Hara, T., M. Schwieger, R. Kazama, S. Okamoto, K. Minehata, M. Ziegler,  J. Löhler, and C. Stocking.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/   sj.onc.121104 3 Harada, N., Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, and  M.M.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1016/j.stem.2012.02.01 7 Holtschke, T., J. Löhler, Y. Kanno, T. Fehr, N. Giese, F. Rosenbauer,  J. Lou, K.P.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81348- 3 Hu, Y., Y. Chen, L. Douglas, and S. Li.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/leu.2008.26 2 Huang, W., W. Zhou, G. Saberwal, I. Konieczna, E. Horvath, E. Katsoulidis,  L.C.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1128/MCB.01595-0 9 Huelsken, J., R. Vogel, B. Erdmann, G. Cotsarelis, and W .",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1016/S0092-   8674(01)00336- 1 Hurtz, C., K. Hatzi, L. Cerchietti, M. Braig, E. Park, Y.M.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1084/jem.2011030 4 Iwasaki, H., and K. Akashi.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1038/sj.onc.121075 4 Jamieson, C.H.M., L.E.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1056/NEJMoa04025 8 Jeannet, G., M. Scheller, L. Scarpellino, S. Duboux, N. Gardiol, J.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/306277a 0 Bonnet, D., and J.E.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/nm0797-73 0 Buesche, G., A. Ganser, B. Schlegelberger, N. von Neuhoff, D. Gadzicki, H.  Hecker, O. Bock, B. Frye, and H. Kreipe.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/sj.leu.240491 7 Burchert, A., D. Cai, L.C.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/   10.1182/blood-2003-08-297 0 Cobas, M., A. Wilson, B. Ernst, S.J.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1084/   jem.2003161 5 Corrêa, S., R. Binato, B.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"12:303. http://dx.doi.org/   10.1186/1471-2407-12-30 3 Crews, L.A., and C.H.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1182/blood-2010-07-29695 4 Deng, M., and G.Q.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1182/blood.V97   .11.349 1 Diaz-Blanco, E., I. Bruns, F .",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/   sj.leu.240454 9 Domen, J., K.L.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1056/NEJMoa06286 7 Duy, C., C. Hurtz, S. Shojaee, L. Cerchietti, H. Geng, S. Swaminathan, L.  Klemm, S.M.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/nature0988 3 Eppert, K., K. Takenaka, E.R.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/nm.241 5 Ergen, A.V ., M. Jeong, K.K.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1007/978-1-62703-128-8_1 0 Fereshteh, M., T. Ito, J.J. Kovacs, C. Zhao, H.Y .",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/3509406 7 Gabriele, L., J. Phung, J. Fukumoto, D. Segal, I.M.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/   10.1128/MCB.24.7.2890-2904.200 4 Nardi, V ., O. Naveiras, M. Azam, and G.Q.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi   .org/10.1182/blood-2008-07-16718 9 Nowell, P.C., and D.A.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"120:2254– 2264. http://dx.doi.org/10.1172/JCI4124 6 Perry, J.M., X.C.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1101/gad.1742191 1 Pollak, M. 2008.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/nrc253 6 Raaijmakers, M.H.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1038/sj.leu.240485 9 Radich, J.P ., H. Dai, M. Mao, V .",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1073/   pnas.051042310 3 Reya, T., A.W.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/nri202 4 Rosenbauer, F ., B.M.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1038/ng167 9 Scheller, M., J. Foerster, C.M.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/ni138 7 Schmidt, M., S. Nagel, J. Proba, C. Thiede, M. Ritter, J.F.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1182/blood.V97.11.364 8 Schwieger, M., J. Löhler, J. Friel, M. Scheller, I. Horak, and C. Stocking.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1084/jem.2002082 4 Shah, N.P ., C. Tran, F .Y .",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
http://dx.doi.org/10.1126/science.109948 0multilineage hematopoiesis occurs in the combined absence of beta- catenin and gamma-catenin.,Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1182/blood-2007-07-10255 8 Jordanides, N.E., H.G.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1182/blood-2006-02-00314 5 Kim, K., K.M.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1091/mbc.11.10.350 9 Kirstetter, P., K. Anderson, B.T.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/ni138 1 Kirstetter, P ., M.B.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1016/   j.ccr.2008.02.00 8 Koch, U., A. Wilson, M. Cobas, R. Kemler, H.R.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/   10.1182/blood-2007-07-09975 4 Koenigsmann, J., and D. Carstanjen.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.3109/1042819090329691 3 Krivtsov, A.V ., D. T womey, Z. Feng, M.C.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/nature0498 0 Kubosaki, A., G. Lindgren, M. Tagami, C. Simon, Y .",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1126/   science.766012 5 Lane, S.W ., Y .J.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1182/blood-2011-03-34516 5 Li, S., R.L.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1016/j.stem.2011.07.01 7 Luis, T.C., N.M. Killmann, and F .J.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1038/leu.2011.26 0 Malhotra, S., and P.W.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1016/j.immuni.2007.02.01 3 Müller-Tidow, C., B. Steffen, T. Cauvet, L. Tickenbrock, P .",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/   bjc.2012.8 1 Tamura, T., H.J.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1182/blood-2003-01-029 1 Tamura, T., P. Thotakura, T.S.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/   10.1182/blood-2005-01-008 0 Wang, Y., A.V.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1126/science.118662 4 Yeung, J., M.T.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"18:606– 618. http://dx.doi.org/10.1016/j.ccr.2010.10.03 2Zhang, W.W., J.E.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1200/JCO.2008.19.407 6 Zhao, C., J. Blum, A. Chen, H.Y.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1016/j.ccr.2007.11.00 3 Zhao, F., A. Mancuso, T.V.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1038/   sj.leu.240422 7 Zhou, S., J.D.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
http://dx.doi.org/10   .1038/nm0901-102 8,Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0   Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"118:149– 161. http://dx.doi.org/10.1016/j.cell.2004.07.00 4 Avagyan, S., L. Glouchkova, J. Choi, and H.W .",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1083/   jcb.20120201 4 Baldridge, M.T., K.Y .",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1038/nature0913 5 Basu, S., N.T.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1182/blood-2011-02-33684 2(EMD Millipore), and antibodies, followed by anti–mouse-HRP (Pro - mega) and the ECL WB detection kit (GE Healthcare), were used for  blot development.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"115:4030– 4038. http://dx.doi.org/10.1182/blood-2009-09-24100 0 Kalaitzidis, D., S.M.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.stem.2012.06.00 9 Kharas, M.G., R. Okabe, J.J. Ganis, M. Gozo, T. Khandan, M. Paktinat,  D.G.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1182/blood-2009-06-22944 3 Knobbe, C.B., V. Lapin, A. Suzuki, and T.W.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1038/onc.2008.23 8 Krutzik, P.O., A. Trejo, K.R.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1126/   science.766012 5 Lander, A.D., J. Kimble, H. Clevers, E. Fuchs, D. Montarras, M.  Buckingham, A.L.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"10:19. http://dx.doi.org/10.1186/1741-7007-10-1 9 Lapidot, T., and I. Petit.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1016/S0301-472X(02)00883- 4 Laterveer, L., I.J.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1016/j.stem.2010.09.01 5 Magee, J.A., T. Ikenoue, D. Nakada, J.Y.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.stem.2012.05.02 6 Matsumoto, A., S. Takeishi, T. Kanie, E. Susaki, I. Onoyama, Y. Tateishi,  K. Nakayama, and K.I.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.stem.2011.06.01 4 Mei, J., Y .",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10   .1172/JCI6058 8 Miletic, A.V ., A.N.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10   .1084/jem.2009196 2 Nervi, B., D.C. Link, and J.F.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1002/jcb.2104 3 Orford, K.W ., and D.T.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1038/nrg226 9Brognard, J., E. Sierecki, T. Gao, and A.C. Newton.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.02.01 7 Chen, M.L., P.Z.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1101/gad.139500 6 Chow, A., D. Lucas, A. Hidalgo, S. Méndez-Ferrer, D. Hashimoto, C. Scheiermann,  M. Battista, M. Leboeuf, C. Prophete, N. van Rooijen, et al.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1084/jem.2010168 8 Christopher, M.J., M. Rao, F. Liu, J.R. Woloszynek, and D.C. Link.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1084/jem.2010170 0 Cross, D.A., D.R.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1038/378785a 0 de Haan, G., and G. Van Zant.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1084/jem.186.4.52 9 Ding, L., T.L.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1038/nature1078 3 Doulatov, S., F .",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10   .1016/j.stem.2012.01.00 6 Ehninger, A., and A. Trumpp.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1084/jem.2011013 2 Essers, M.A., and A. Trumpp.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10   .1016/j.molonc.2010.06.00 1 Essers, M.A., S. Offner, W.E.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10   .1038/nature0781 5 Freeman, D., R. Lesche, N. Kertesz, S. W ang, G. Li, J. Gao, M. Groszer, H. Martinez- Diaz, N. Rozengurt, G. Thomas, et al.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-05-414 3 Göthert, J.R., S.E.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1182/blood-2004-08-303 7 Groszer, M., R. Erickson, D.D.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10   .1126/science.106551 8 Gu, T., Z. Zhang, J. Wang, J. Guo, W.H.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-10-339 9 Guo, W., J.L.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1038/nature0693 3 Hasegawa, M., T.M.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
http://dx.doi   .org/10.1182/blood.V99.11.394 7,Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1038/nm163 6 Park, D., D.B.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.2741/   3913 Qian, H., N. Buza-Vidas, C.D.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1016/j.stem.2007.10.00 8 Song, M.S., L. Salmena, and P.P.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"13:283– 296. http://dx.doi.org/10.1038/nrm333 0 Sugiyama, T., H. Kohara, M. Noda, and T. Nagasawa.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.10.01 6 Svensson, R.U., J.M.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.ajpath.2011.03.01 4 Szilvassy, S.J., R.K. Humphries, P.M. Lansdorp, A.C. Eaves, and C.J.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.stem.2011   .08.00 5 Tesio, M., K. Golan, S. Corso, S. Giordano, A. Schajnovitz, Y. Vagima,  S. Shivtiel, A. Kalinkovich, L. Caione, L. Gammaitoni, et al.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1182/blood-2009-06-23035 9 Tothova, Z., and D.G.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.stem.2007.07.01 7 Van Zant, G., P.W.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10   .1016/0092-8674(83)90096- X Vivanco, I., N. Palaskas, C. Tran, S.P.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.ccr.2007.04.02 1 Wilson, A., M.J. Murphy, T. Oskarsson, K. Kaloulis, M.D.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1101/gad.31310 4 Wilson, A., E. Laurenti, G. Oser, R.C.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10   .1016/j.cell.2008.10.04 8 Winkler, I.G., N.A.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1182/blood-2009-11-25353 4 Xu, P.Z., M.L.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1038/onc.2011.24 3 Yamazaki, S., A. Iwama, S. Takayanagi, Y. Morita, K. Eto, H. Ema, and H.  Nakauchi.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1038/sj.emboj.760123 6 Yamazaki, S., H. Ema, G. Karlsson, T. Yamaguchi, H. Miyoshi, S. Shioda,  M.M.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/   j.cell.2011.09.05 3 Yilmaz, O.H., R. Valdez, B.K.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1016/j.stem.2007.10.02 0 Yu, H., Y. Yuan, H. Shen, and T. Cheng.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/10.1182/blood-2005-   02-068 5 Zhang, J., J.C. Grindley, T. Yin, S. Jayasinghe, X.C.",Non-OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
"http://dx.doi.org/   10.1038/nature0474 7 Zou, P., H. Yoshihara, K. Hosokawa, I. Tai, K. Shinmyozu, F. Tsukahara,  Y. Maru, K. Nakayama, K.I.",OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
http://dx.doi.org/10.1016/j.stem.2011.07.00 3,OADS,/arxiv_data1/oa_pdf/85/4a/JEM_20122768.PMC3804947.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20121999/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1038/   nn201 4 Ajami, B., J.L.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi   .org/10.1038/nn.288 7 Alikhan, M.A., C.V .",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
http://dx.doi.org/10.1126/science.117605 6saline solution containing 2 mM EDTA (Invitrogen).,Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1016/j.cyto.2012.08.00 8 Hamilton, J.A.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1038/nri235 6 Hashimoto, D., A. Chow, C. Noizat, P .",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1016/j.immuni.2013.04.00 4 Heller, N.M., X. Qi, I.S.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1126/scisignal.116479 5 Herbert, D.R., C. Hölscher, M. Mohrs, B. Arendse, A. Schwegmann, M.  Radwanska, M. Leeto, R. Kirsch, P .",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1016/S1074 ­7613  (04)00107­ 4 Hume, D.A.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10   .1189/jlb.081047 2 Hume, D.A., and K.P .",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10   .1182/blood­2011­09­37921 4 Hume, D.A., P. Pavli, R.E.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1016/j.cellsig.2012.04.02 2 Irvine, K.M., C.J.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1096/   fj.06­5848fj e Jenkins, S.J., and J.E.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"2010:262609. http://dx.doi.org/10.1155/2010/26260 9 Jenkins, S.J., D. Ruckerl, P.C.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10   .1126/science.120435 1 Kanitakis, J., P. Petruzzo, and J.M.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1056/NEJM20041216351252 3 Karp, C.L., and P.J.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1084/   jem.2012029 5 Klein, I., J.C. Cornejo, N.K.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1182/blood ­2007­02­07384 1 Landberg, G., E.M. Tan, and G. Roos.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1016/0014­4827(90)90124­ S Le Goff, L., T.J. Lamb, A.L.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1016/S0020­7519(02)00125­ X Lenda, D.M., E. Kikawada, E.R.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1017/S0022149X0000746 X Bunting, K.D., W.M.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi   .org/10.1189/jlb.090344 0 Chensue, S.W ., K.S.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1016/j.coi.2005.11.00 6 Chorro, L., A. Sarde, M. Li, K.J.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1084/jem   .2009158 6 Conway, J.G., B. McDonald, J. Parham, B. Keith, D.W .",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1182/blood.V99.1.11 1 Davies, L.C., M. Rosas, P .J.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1002/eji.20114181 7 Davies, L.C., M. Rosas, S.J.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"4:1886. http://dx.doi.org/10   .1038/ncomms287 7 DeNardo, D.G., J.B. Barreto, P .",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.06.01 8 Dewals, B.G., R.G.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1371/journal   .pntd.000068 9 Finkelman, F .D., K.B.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi   .org/10.1016/j.immuni.2010.05.00 7 Gow, D.J., V .",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1126/science.121917 9 Smith, J.L., A.E.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"20:8026– 8034. http://dx.doi.org/10.1128/MCB.20.21.8026­8034.200 0 Tagliani, E., C. Shi, P .",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1084/jem.2011086 6 Thomas, G.D., D. Rückerl, B.H.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1182/   blood­2012­07­44264 0 Tushinski, R.J., I.T.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1016/0092 ­8674(82)90376 ­2 Ulich, T.R., J. del Castillo, L.R.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"4:255) http://dx.doi.org/10.1016/j.cmet.2006.05.01 1 Verreck, F .A., T. de Boer, D.M.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1073/   pnas.040098310 1 Volkman, A., N.C. Chang, P.H.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1126/   science.120147 5 Wurster, A.L., V.L.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1074/jbc.M20120720 0 Yona, S., K.W.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
http://dx.doi.org/10   .1016/j.immuni.2012.12.00 1colony­stimulating factor­1­deficient mice results in decreased tubular  apoptosis during renal inflammation.,Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1172/JCI4544 4 Linde, N., W .",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1002/path.398 9 Loke, P ., I. Gallagher, M.G.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1084/   jem.187.4.60 1 MacDonald, K.P ., J.S.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1182/blood­2010­02­26629 6 Martinez, F.O., S. Gordon, M. Locati, and A. Mantovani.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1165/rcmb.2007­0224R C Murray, P .J., and T.A.",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1038/nri307 3 Nguyen, K.D., Y .",OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1038/nature1065 3 Noben­Trauth, N., G. Köhler, K. Bürki, and B. Ledermann.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1007/BF0198021 4 Pello, O.M., M. De Pizzol, M. Mirolo, L. Soucek, L. Zammataro, A. Amabile,  A. Doni, M. Nebuloni, L.B.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/   10.1182/blood­2011­02­33991 1 Priceman, S.J., J.L.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
"http://dx.doi.org/10.1182/blood­   2009­08­23741 2 Rückerl, D., S.J.",Non-OADS,/arxiv_data1/oa_pdf/c0/a9/JEM_20121999.PMC3804948.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
Black triangles denote genes reported in the Cancer Gene Census database (http://www.sanger.ac.uk/genetics/CGP/Census/); green triangles indicate puta - tive or proven tumor suppressor genes; and red triangles denote putative or proven oncogenes.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20131448/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"12:115– 130. http://dx.doi.org/10.1016/j.ccr.2007.07.00 4 Aparicio, S., and C. Caldas.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1056/NEJMra120489 2 Baumann, P., and T.R.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1074/jbc   .M109.01628 7 Beroukhim, R., G. Getz, L. Nghiemphu, J. Barretina, T. Hsueh, D. Linhart,  I. Vivanco, J.C. Lee, J.H.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/377635a 0total depth, its observed frequency in the paired sample, and the estimates for  samples’ tumor contents, using a binomial distribution.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"Genes found to be altered in RS were assigned to functional categories or   to annotated pathways using the gene ontology GO database (http://www   .geneontology.org/), the publicly available bioinformatic tool DAVID 2008 6.7  (Database for Annotation, Visualization and Integrated Discovery, http://david   .abcc.ncifcrf.gov/), and the Molecular Signatures Database from the Broad Insti - tute (MSigDBv4.0, http://www.broadinstitute.org/gsea/msigdb/index.jsp).",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1093/nar/gkn92 3 Huang, W., B.T.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/nprot.2008.21 1 Huang, F.W., E. Hodis, M.J. Xu, G.V.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1126/science.122925 9 Keats, J.J., R. Fonseca, M. Chesi, R. Schop, A. Baker, W.J.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1016/j.ccr   .2007.07.00 3 Kikushige, Y., F. Ishikawa, T. Miyamoto, T. Shima, S. Urata, G. Yoshimoto,  Y. Mori, T. Iino, T. Yamauchi, T. Eto, et al.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1016/j.ccr.2011.06.02 9 Kulis, M., S. Heath, M. Bibikova, A.C. Queirós, A. Navarro, G. Clot, A.  Martínez-Trillos, G. Castellano, I. Brun-Heath, M. Pinyol, et al.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/ng.244 3 Küppers, R., and R. Dalla-Favera.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1038/sj.onc.120464 0 Kuroda, K., H. Han, S. Tani, K. Tanigaki, T. Tun, T. Furukawa, Y.  Taniguchi, H. Kurooka, Y. Hamada, S. Toyokuni, and T. Honjo.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1016/j.cell.2013.01.01 9 Li, H., and R. Durbin.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btp69 8 Lohr, J.G., P. Stojanov, M.S.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1128/MCB.01094-1 0 Monti, S., B. Chapuy, K. Takeyama, S.J.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.07.01 4 Mootha, V.K., C.M.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/ng118 0 Morin, R.D., M. Mendez-Lago, A.J.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/nature1035 1 Ouillette, P., S. Fossum, B. Parkin, L. Ding, P. Bockenstedt, A. Al-Zoubi, K.  Shedden, and S.N.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1158/1078-0432.CCR-09-253 4 Ouillette, P., K. Saiya-Cork, E. Seymour, C. Li, K. Shedden, and S.N.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1016/j.ccr.2011.11.00 6 Coiffier, B., E. Lepage, J. Briere, R. Herbrecht, H. Tilly, R. Bouabdallah,  P. Morel, E. Van Den Neste, G. Salles, P. Gaulard, et al.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"346:235– 242. http://dx.doi.org/10.1056/NEJMoa01179 5 Davies, A.J., A. Rosenwald, G. Wright, A. Lee, K.W.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
http://dx.doi.org/10.1111/j.1365-2141.2006.06439.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1084/jem.178.5.166 5 Edelmann, J., K. Holzmann, F. Miller, D. Winkler, A. Bühler, T. Zenz,  L. Bullinger, M.W.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1084/jem.2011092 1 Fine, B., C. Hodakoski, S. Koujak, T. Su, L.H.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/   10.1126/science.117356 9 Golas, M.M., B. Sander, C.L.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1126/science.108415 5 Grasso, C.S., Y.M.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/nature1112 5 Hallek, M., B.D.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1182/   blood-2007-06-09390 6 Hannon, G.J., and D. Beach.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1038/371257a 0 Hans, C.P., D.D.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1182/blood-2003-05-154 5 He, L., J.M.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
http://dx.doi.org/10   .1038/nature0355 2,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1016/S1074-7613(03)00111- 0 Samon, J.B., M. Castillo-Martin, M. Hadler, A. Ambesi-Impiobato,  E. Paietta, J. Racevskis, P.H.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1158/1535-7163.MCT-11-093 8 Schuh, A., J. Becq, S. Humphray, A. Alexa, A. Burns, R. Clifford, S.M.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1182/blood-2012-05-43354 0 Serrano, M., G.J.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/366704a 0 Sherr, C.J.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"353:26– 29. http://dx.doi.org/10.1016/S0140-6736(98)10117- 4 Subramanian, A., P. Tamayo, V.K.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/ng152 8 Swerdlow, S.H.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1056/NEJMoa101420 9 Tsimberidou, A.M., S. O’Brien, I. Khouri, F.J. Giles, H.M. Kantarjian, R.  Champlin, S. Wen, K.A.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1200/JCO.2005.05.018 7 Tsimberidou, A.M., W.G.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1200/JCO.2007.11.851 3 Vaux, D.L., S. Cory, and J.M.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/335440a 0 Walter, M.J., D. Shen, L. Ding, J. Shao, D.C. Koboldt, K. Chen, D.E.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1056/NEJMoa110696 8 Wang, H., and H.C. Morse III.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi   .org/10.1007/s12026-008-8055- 8 Wang, L., M.S.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1056/NEJMoa110901 6 Weng, A.P., A.A. Ferrando, W. Lee, J.P. Morris IV, L.B.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1158/1078-0432.CCR-13-013 8 Palomero, T., W.K.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/ng.89 2 Puente, X.S., M. Pinyol, V. Quesada, L. Conde, G.R.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/   nature1011 3 Quesada, V., L. Conde, N. Villamor, G.R.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/ng.258 4 Rausch, T ., D.T .",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1038/nri319 0 Rossi, D., and G. Gaidano.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1002/   hon.88 0 Rossi, D., M. Cerri, D. Capello, C. Deambrogi, F.M.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
http://dx.doi.org/10.1111/   j.1365-2141.2008.07166.,Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1182/blood-2011-08-37315 9 Rossi, D., V. Spina, C. Deambrogi, S. Rasi, L. Laurenti, K. Stamatopoulos,  L. Arcaini, M. Lucioni, G.B.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1084/jem.2012090 4 Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T.  Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1126/science   .110216 0 Wu, J.N., and C.W.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"464:1052– 1057. http://dx.doi.org/10.1038/nature0887 8 Xiao, C., L. Srinivasan, D.P.",Non-OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10   .1038/ni157 5Yano, T., E.S.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
"http://dx.doi.org/10.1200/JCO.2009.27.876 2 Zhang, Y., Y. Xiong, and W.G.",OADS,/arxiv_data1/oa_pdf/e3/b0/JEM_20131448.PMC3804949.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"61:1169– 1179. http://dx.doi.org/10.2337/db11-067 1 French, M.B., J. Allison, D.S.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.2337/   diab.46.1.3 4 Gagnerault, M.C., J.J. Luan, C. Lotton, and F .",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1084/jem.2001135 3 Gonzalez, A., I. Andre-Schmutz, C. Carnaud, D. Mathis, and C. Benoist.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"2:1117– 1125. http://dx.doi.org/10.1038/ni73 8 Halbout, P., J.P. Briand, C. Bécourt, S. Muller, and C. Boitard.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1084/jem.189.2.33 1 Jaeckel, E., M.A.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1038/ni112 0 Jasinski, J.M., L. Yu, M. Nakayama, M.M.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.2337/db06-005 8 Kobayashi, M., J. Jasinski, E. Liu, M. Li, D. Miao, L. Zhang, L. Yu, M.  Nakayama, and G.S.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1172/JCI2960 2 Krishnamurthy, B., L. Mariana, S.A. Gellert, P .G.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1093/intimm/dxg14 3 Levisetti, M.G., A. Suri, K. Frederick, and E.R.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.2337/diabetes.53.12.311 5 Levisetti, M.G., A. Suri, S.J.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1084/jem.2011259 3 Mohan, J.F., and E.R.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1038/nri329 4Submitted: 19 March 2013 Accepted: 11 September 2013 REFERENCES Abiru, N., D. Wegmann, E. Kawasaki, P. Gottlieb, E. Simone, and G.S.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1006/jaut.2000.036 9 Abiru, N., A.K.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.2337/diabetes.50.6.127 4 Acha-Orbea, H., and H.O.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi   .org/10.1146/annurev.immunol.23.021704.11564 3 Anderson, M.S., E.S.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10   .1126/science.107595 8 Calderon, B., and E.R.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/   10.1016/j.coi.2011.11.00 5 Calderon, B., A. Suri, M.J. Miller, and E.R.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/   10.1371/journal.pone.005970 1 Chen, Z., A.E.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1084/jem.2005140 9 Crawford, F., B. Stadinski, N. Jin, A. Michels, M. Nakayama, P. Pratt, P.  Marrack, G. Eisenbarth, and J.W.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10   .1093/hmg/10.19.202 5 Daniel, D., R.G.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1002/eji.183025043 0 Du, W., F.S.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1038/ni.185 0 Mohan, J.F ., S.J.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1084/jem   .2011150 2 Nakayama, M., N. Abiru, H. Moriyama, N. Babaya, E. Liu, D. Miao, L. Y u, D.R.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1038/nature0352 3 Nakayama, M., J.N.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi   .org/10.1172/JCI3136 8 Rennert, P.D., J.L.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1084/jem.184.5.199 9 Rennert, P.D., D. James, F. Mackay, J.L.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1016/   S1074-7613(00)80589- 0 Salvalaggio, P.R., S. Deng, C.E.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10   .1097/00007890-200209270-0002 3 Turley, S., L. Poirot, M. Hattori, C. Benoist, and D. Mathis.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1084/jem.2003096 6 Wang, Q., L. Malherbe, D. Zhang, K. Zingler, N. Glaichenhaus, and  N. Killeen.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1006/jaut.1994   1066 Wegmann, D.R., M. Norbury-Glaser, and D. Daniel.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1002/   eji.183024082 0 Yu, B., L. Gauthier, D.H. Hausmann, and K.W.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1002/1521-4141(200009)30:   9<2497::AID-IMMU2497>3.0.CO;2- J Zal, T., A. Volkmann, and B. Stockinger.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1084/jem.180.6.208 9 Zhang, Y., B. O’Brien, J. Trudeau, R. Tan, P. Santamaria, and J.P. Dutz.",Non-OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
"http://dx.doi.org/10.1016/j.coi.2007.11.00 5 Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis.",OADS,/arxiv_data1/oa_pdf/19/6c/JEM_20130582.PMC3804950.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1016/1074-7613(94)90076- 0 Axelsson, J., D. Xu, B.N.",OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
http://dx.doi.org/10.1182/blood-2012-   03-41713 9system (GlycoTech) coated either with 5 µg/ml PSGL-1 alone (disulfide- linked homodimer; R&D Systems) or in combination with 5 µg/ml  ICAM-1 (R&D Systems).,Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1084/jem.2011149 3 Bruehl, R.E., T .A.",OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/   10.1083/jcb.20010304 2 Giblin, P.A., S.T.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1084/jem.193.7.86 3 Herter, J.M., J. Rossaint, H. Block, H. Welch, and A. Zarbock.",OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi   .org/10.1182/blood-2012-09-45708 5 Kansas, G.S.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
100:287– 293. http://dx.doi.org/10.1111/j.1699-0463.1992.tb00874.,Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
http://dx.doi.org/   10.1046/j.1365-2141.2001.03179.,Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi   .org/10.1182/blood-2010-01-26612 2 Lefort, C.T ., J. Rossaint, M. Moser, B.G.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1182/blood-2011-08-37311 8 Lewinsohn, D.M., R.F .",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/   10.1084/jem.181.2.66 9 Miner, J.J., L. Xia, T .",OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/   10.1182/blood-2008-04-14946 8 Mueller, H., A. Stadtmann, H. Van Aken, E. Hirsch, D. Wang, K. Ley, and A.  Zarbock.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/   10.1182/blood-2004-01-019 1 Sikorski, M.A., D.E.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1002/eji.20104119 6 Sundd, P ., E. Gutierrez, E.K.",OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1038/nature1124 8 Urzainqui, A., J.M.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1016/S1074-7613(02)00420- X Venturi, G.M., L. Tu, T. Kadono, A.I.",OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1016/S1074-7613(03)00295- 4 Waddell, T.K., L. Fialkow, C.K.",OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"270:15403– 15411. http://dx.doi.org/10.1074/jbc.270.25.1540 3 Watson, S.R., C. Fennie, and L.A. Lasky.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1038/349164a 0 Xia, L., M. Sperandio, T. Yago, J.M.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1182/   blood-2009-12-25955 6 Zarbock, A., C.A.",Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
"http://dx.doi.org/10.1084/jem.2007266 0 Zarbock, A., K. Ley, R.P .",OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
http://dx.doi.org/10   .1182/blood-2011-07-34356 6,Non-OADS,/arxiv_data1/oa_pdf/0e/fa/JEM_20130664.PMC3804951.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first  six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1084/jem   .191.11.189 5 Chiba, A., R. Tajima, C. T omi, Y .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1002/art.3331 4 Chua, W .J., S.M.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1128/IAI.00279-1 2 Cosgrove, C., J.E.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1182/blood-2012-06-43643 6buffer (1× PBS with 2% FBS), pelleted, and stained with 20 µg/ml PE-   conjugated negative control mouse MR1-K43A tetramer (empty) or PE- conjugated rRL-6-CH2OH–loaded mouse MR1 tetramer in 10 µl (final  volume) FACS staining buffer (in FACS tubes; BD) for 45 min at room  temperature in the dark.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1016/S1074-   7613(02)00513- 7 Kjer-Nielsen, L., O. Patel, A.J.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/   10.1016/j.it.2011.02.00 5 Le Bourhis, L., Y.K.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1016/j.coi.2013.01.00 5 Leeansyah, E., A. Ganesh, M.F.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1182/blood-2012-07-44542 9 Leslie, A.G. 2006.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1107/   S090744490503910 7 Ly, D., A.G. Kasmar, T.Y .",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1084/jem.2012062 4 Mallevaey, T., J.P. Scott-Browne, J.L.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.05.01 0 Martin, E., E. Treiner, L. Duban, L. Guerri, H. Laude, C. Toly, V. Premel,  A. Devys, I.C.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi   .org/10.1371/journal.pbio.100005 4 Maru, Y ., O. Y okosuka, F .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/   10.1159/00007320 7 Matsuda, J.L., O.V .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1084/jem.192.5.74 1 Matulis, G., J.P .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1093/intimm/dxr04 7Croxford, J.L., S. Miyake, Y .Y .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1038/ni137 0 Das, G., D.S.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"193:413) http://dx.doi   .org/10.1084/jem.192.10.152 1 Davis, M.M., J.D.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1038/nri302 0 de Kauwe, A.L., Z. Chen, R.P .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.4049/jimmunol.090023 3 Dusseaux, M., E. Martin, N. Serriari, I. Péguillet, V .",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1182/blood-2010-   08-30333 9 Ebato, M., T. Nitta, H. Yagita, K. Sato, and K. Okumura.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1002/eji.183024121 0 Gao, G.F ., J. Tormo, U.C.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1038/4252 3 Gold, M.C., and D.M.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"11:14– 19. http://dx.doi.org/10.1038/nrmicro291 8 Gold, M.C., S. Cerri, S. Smyk-Pearson, M.E.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1371/journal.pbio.100040 7 Gold, M.C., T. Eid, S. Smyk-Pearson, Y .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1038/mi.2012.4 5 Griffith, I.J., N. Nabavi, Z. Ghogawala, C.G.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1084/jem.167.2.54 1 Huang, S., S. Gilfillan, M. Cella, M.J. Miley, O. Lantz, L. Lybarger, D.H.  Fremont, and T.H.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"280:21183– 21193. http://dx.doi.org/10.1074/jbc.M50108720 0 Hwang, H.Y ., T.G.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1016/j.molimm.2005.03.00 4 Kasmar, A.G., I. van Rhijn, T.Y .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1126/science.278.5343.162 6 Kjer-Nielsen, L., C.S.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10   .1016/j.chembiol.2005.04.01 4 Patel, O., D.G.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.04.01 8 Reantragoon, R., L. Kjer-Nielsen, O. Patel, Z. Chen, P .T.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi   .org/10.1084/jem.2011209 5 Rossjohn, J., D.G.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1038/nri332 8 Tilloy, F ., E. Treiner, S.H.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1084/jem.189.12.190 7 Treiner, E., L. Duban, S. Bahram, M. Radosavljevic, V .",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"422:164– 169. http://dx.doi.org/10.1038/nature0143 3 T ynan, F .E., H.H.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1038/ni143 2 Van Damme, N., M. De Vos, D. Baeten, P .",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1136/ard.60.5.49 5 Van Rhijn, I., A. Kasmar, A. de Jong, S. Gras, M. Bhati, M.E.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10   .1038/ni.263 0 Walker, L.J., Y .H.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10   .1182/blood-2011-05-35378 9 Wang, G.C., P .",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"203:1197– 1207. http://dx.doi.org/10.1084/jem.2006041 8 Y oung, M.H., and L. Gapin.",OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10   .1038/cr.2012.16 8 Y oung, M.H., L. U’Ren, S. Huang, T. Mallevaey, J. Scott-Browne, F .",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
"http://dx.doi.org/10.1371/journal   .pone.005378 9 Zwart, P .H., P .V .",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
http://dx.doi.org/10.1007/978-1-60327-058-8_2 8,Non-OADS,/arxiv_data1/oa_pdf/bf/3e/JEM_20130958.PMC3804952.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1038/nm154 1 Ding, W., J.A.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1038/   sj.jid.570085 8 Ding, W., L.L.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1038/mi.2010.3 2 Ganor, Y., Z. Zhou, J. Bodo, D. Tudor, J. Leibowitch, D. Mathez, A.  Schmitt, M.C.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1038/mi.2012.11 6 Geijtenbeek, T.B., D.S.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80694- 7 Geissmann, F., C. Prost, J.P. Monnet, M. Dy, N. Brousse, and O. Hermine.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1084/   jem.187.6.96 1 Griffiths, C.E., D. Railan, W.M.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
http://dx.doi.org/10.1111/j.1365-2133.1995.tb06911.,Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1038/363159a 0 Magérus-Chatinet, A., H. Yu, S. Garcia, E. Ducloux, B. Terris, and M.  Bomsel.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/j.virol   .2006.11.03 5 Masterson, A.J., C.C.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1182/blood.V100.2.70 1 Mc Dermott, R., U. Ziylan, D. Spehner, H. Bausinger, D. Lipsker, M.  Mommaas, J.P. Cazenave, G. Raposo, B. Goud, H. de la Salle, et al.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/   10.1091/mbc.01-06-030 0 McCarthy, B.G., S.T.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1212/WNL.45.10.184 8 Moreno, M.J., J.A.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/S0028-3908(01)00176- 9ethical committee of the San Raffaele Scientific Institute, the Comitato  Etico dell’Istituto Scientifico Ospedale San Raffaele, approved the investiga - tions.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/S0304-   3940(98)00236- 5 Asahina, A., O. Moro, J. Hosoi, E.A.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/   j.peptides.2005.11.01 4 Blanco-Melo, D., S. Venkatesh, and P.D.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"37:399– 411. http://dx.doi.org/10.1016/j.immuni.2012.08.01 3 Bomsel, M., D. Tudor, A.S. Drillet, A. Alfsen, Y. Ganor, M.G.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.01.01 5 Brain, S.D., T.J. Williams, J.R. Tippins, H.R.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
http://dx.doi.org/10.1038/313054a 0,Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1056/NEJMoa03050 5 Poyner, D.R., P.M. Sexton, I. Marshall, D.M.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1124/   pr.54.2.23 3 Rosenfeld, M.G., J.J. Mermod, S.G. Amara, L.W.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1038/   304129a 0 Sams, A., and I. Jansen-Olesen.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/S0304-   3940(98)00844- 1Schifter, S. 1997.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/   S0196-9781(96)00169- 6 Torii, H., J. Hosoi, S. Beissert, S. Xu, F.E.",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1016/j.tips.2010.06.00 6 Zhou, L., D.W .",OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
"http://dx.doi.org/10.1212/01.wnl.0000264888.87918.a 1 Zhou, Z., N. Barry de Longchamps, A. Schmitt, M. Zerbib, M.C.",Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
http://dx.doi.org/10.1371/journal.ppat.100210 0,Non-OADS,/arxiv_data1/oa_pdf/24/13/JEM_20122349.PMC3804954.pdf
This article is distributed under the terms of an Attribu - tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20130376/DC1.,Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
Lentiviral production was performed accord - ing to publicly available protocols (http://www.broadinstitute.org/rnai/   public/resources/protocols).,OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1074/jbc.C60032220 0 Araki, Y., Z. Wang, C. Zang, W.H.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.05.00 6 Bandukwala, H.S., J. Gagnon, S. Togher, J.A.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1038/ni.169 0 Bettelli, E., Y.",Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1038/nature0475 3 Brüstle, A., S. Heink, M. Huber, C. Rosenplänter, C. Stadelmann, P. Yu,  E. Arpaia, T.W.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1038/ni150 0 Chen, G., K. Hardy, E. Pagler, L. Ma, S. Lee, S. Gerondakis, S. Daley, and M.F .",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.4049/   jimmunol.110175 7 Chung, Y., S.H.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1016/j.immuni   .2009.02.00 7 Ciofani, M., A. Madar, C. Galan, M. Sellars, K. Mace, F. Pauli, A. Agarwal,  W. Huang, C.N.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi   .org/10.1038/nature1050 9 Esplugues, E., S. Huber, N. Gagliani, A.E.",Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1038/nature1022 8 Filippakopoulos, P., J. Qi, S. Picaud, Y. Shen, W.B.",Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/   10.1038/nature0950 4 Glasmacher, E., S. Agrawal, A.B.",Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1126/science.122830 9 Hargreaves, D.C., T. Horng, and R. Medzhitov.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1016/j.cell.2009.05.04 7 Ivanov, I.I., B.S.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1016/   j.cell.2006.07.03 5 Korn, T., E. Bettelli, M. Oukka, and V.K.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1146/   annurev.immunol.021908.13271 0 Littman, D.R., and A.Y.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1038/nature0958 9 Nurieva, R., X.O.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1038/nature0596 9 Ramirez-Carrozzi, V.R., D. Braas, D.M.",Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1084/jem.2011046 2 Schraml, B.U., K. Hildner, W. Ise, W.L.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10.1038/nature0688 1 Wei, G., L. Wei, J. Zhu, C. Zang, J. Hu-Li, Z. Yao, K. Cui, Y. Kanno,  T.Y.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/   10.1016/j.immuni.2007.11.01 6 Zhou, L., I.I.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"http://dx.doi.org/10   .1038/ni148 8 Zuber, J., J. Shi, E. Wang, A.R.",OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
http://dx.doi.org/10.1038/nature1033 4,Non-OADS,/arxiv_data1/oa_pdf/10/e9/JEM_20130376.PMC3804955.pdf
"Before launching the study website (http://ptstudy.ksu.edu.sa), two pilot studies were conducted to examine the content valid - ity and the test–retest reliability of the questionnaire, which helped in its further amendment.",Non-OADS,/arxiv_data1/oa_pdf/8b/a2/jpts-25-649.PMC3804976.pdf
http://www.wcpt.org/node/29550.,Non-OADS,/arxiv_data1/oa_pdf/8b/a2/jpts-25-649.PMC3804976.pdf
http://www.index.go.kr/egarns/stts/jsp/potal/stts/PO_STTS_IdxMain.,OADS,/arxiv_data1/oa_pdf/42/ff/jpts-25-631.PMC3804989.pdf
"http://www.wikihow.com/Cure-TMJ- with-Jaw-Exercises	(Accessed	Aug.	10,	2012).",Non-OADS,/arxiv_data1/oa_pdf/93/77/jpts-25-583.PMC3804991.pdf
http://www.claycox.net/rolfing_2.htm	(Accessed	Apr.,Non-OADS,/arxiv_data1/oa_pdf/93/77/jpts-25-583.PMC3804991.pdf
"Correspondence to: Sophia K. Khaldoyanidi at skhaldoyanidi@tpims.org URL: http://www.jove.com/video/50959 DOI: doi:10.3791/50959 Keywords: Bioengineering, Issue 77, Cellular Biology, Biophysics, Physiology, Molecular Biology, Biomedical Engineering, Immunology, Cells, Biological Factors, Equipment and Supplies, Cell Physiological Phenomena, Natural Science Disciplines, Life Sciences (General), circulating cells, extravasation, physiological shear stress, endothelial cells, microenvironment, chemokine gradient, flow, chamber, cell culture, assay Date Published: 7/15/2013 Citation: Goncharova, V., Khaldoyanidi, S.K.",Non-OADS,/arxiv_data1/oa_pdf/ec/43/jove-77-50959.PMC3805051.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50959/ Introduction Cell extravasation is the process by which circulating cells exit the bloodstream and is a critical component of many physiological responses in the body.,Non-OADS,/arxiv_data1/oa_pdf/ec/43/jove-77-50959.PMC3805051.pdf
Available from: http://www.patentgenius.com/patent/7860283.html 15.,Non-OADS,/arxiv_data1/oa_pdf/c7/fa/hi-2013-1-e2.PMC3805166.pdf
Available from: http://www.patentgenius.com/patent/ 7940970.html 16.,Non-OADS,/arxiv_data1/oa_pdf/c7/fa/hi-2013-1-e2.PMC3805166.pdf
Available from: http://www.patentge- nius.com/patent/7940977.html 17.,Non-OADS,/arxiv_data1/oa_pdf/c7/fa/hi-2013-1-e2.PMC3805166.pdf
Available from: http://www.patentgenius.com/patent/79834 59.html 18.,Non-OADS,/arxiv_data1/oa_pdf/c7/fa/hi-2013-1-e2.PMC3805166.pdf
Available from: http://www.patentgenius.com/patent/81030 74.html 19.,Non-OADS,/arxiv_data1/oa_pdf/c7/fa/hi-2013-1-e2.PMC3805166.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/28/tacg-6-087.PMC3805180.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2013:6 87–90The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  87CAse repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S4777 7Dubowitz syndrome: common findings   and peculiar urine odor Cynthia Chehade1 Johnny Awwad2 Nadine Yazbeck1 Marianne Majdalani1 rima Wakim1 Hala Tfayli1 Chantal Farra1,3 1Department of p ediatrics and  Adolescent Medicine, American  University of Beirut Medical Center,   Beirut, Lebanon; 2Department of  Obstetrics and Gynecology, American  University of Beirut Medical Center,   Beirut, Lebanon; 3Department of  Pathology and Laboratory Medicine,   American University of Beirut Medical  Center, Beirut, Lebanon Correspondence: Chantal Farra   Department of pediatrics and Adolescent  Medicine, American University of Beirut  Medical Center, po Box 11-0236, riad el  solh 1107 2020, Beirut, Lebanon   Tel +961 1 350000 ext.5427   Fax +961 1 370845   email cf07@aub.edu.l bBackground:  Dubowitz syndrome is a rare, autosomal recessive disorder characterized by  intrauterine and postnatal growth retardation, severe microcephaly, psychomotor retardation,  hyperactivity, eczema, and characteristic dysmorphic facial features.",Non-OADS,/arxiv_data1/oa_pdf/70/28/tacg-6-087.PMC3805180.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/70/28/tacg-6-087.PMC3805180.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/28/tacg-6-087.PMC3805180.pdf
"Available from: http://www.cdc.gov/growthcharts/clinical_chart s.  Accessed July 7, 2013.",OADS,/arxiv_data1/oa_pdf/70/28/tacg-6-087.PMC3805180.pdf
"Cambridge, MA: Harvard University; 2010;  Available from: http://www.health.harvard.edu/newsletters/Harvard_ Womens_Health_Watch/2010/June/urine-color-and-odor-change s.  Accessed July 7, 2013.",Non-OADS,/arxiv_data1/oa_pdf/70/28/tacg-6-087.PMC3805180.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/tacg-6-091.PMC3805181.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2013:6 91–101The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  91Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S3192 8Developments in the treatment of hemophilia B:  focus on emerging gene therapy Maria i Cancio1 Ulrike M Reiss2 Amit C Nathwani3 Andrew M Davidoff4 John T Gray2 1Department of Hematology-Oncology,  2Department of Hematology,   St Jude Children’s Research Hospital,  Memphis, TN, USA; 3Department  of Haematology, University College  London Cancer institute, London,   UK; 4Department of Surgery,   St Jude Children’s Research Hospital,  Memphis, TN, USA Correspondence: John T Gray   Department of Hematology,   St. Jude Children’s Research Hospital,  262 Danny Thomas Place, Mail Stop 910,  Memphis, TN 38105, USA   Tel +1 901 595 4729   Fax +1 901 595 2176   email john.gray@stjude.or gAbstract:  Hemophilia B is a genetic disorder that is characterized by a deficiency of clotting  factor IX (FIX) and excessive bleeding.",Non-OADS,/arxiv_data1/oa_pdf/c3/aa/tacg-6-091.PMC3805181.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/c3/aa/tacg-6-091.PMC3805181.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/aa/tacg-6-091.PMC3805181.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/33/d5/amep-4-201.PMC3805182.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 201–216Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  201OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S4676 2The rEDih experience: an emerging design   to develop an effective training program   for graduate students in reproductive science colla J MacDonald1 Douglas Archibald2 Jay M Baltz3 gerald M Kidder4 1Faculty of Education, 2Department  of Family Medicine, University of  Ottawa, Ottawa, On , canada; 3Ottawa  hospital research institute, Ottawa,   On, canada; 4schulich school of  Medicine and Dentistry, University  of Western Ontario, london, On ,   canada correspondence: colla J MacDonald   145 Jean Jacques lussier,   University of Ottawa,   Ottawa, On K1n6n5, canada   Email cjmacdon@uottawa.c aBackground:  A training program in Reproduction, Early Development, and the Impact on  Health (REDIH) was initiated in 2009 by researchers specializing in biomedical, clinical,  population health, and ethics research from seven collaborating universities in Quebec and  Ontario, and Health Canada.",Non-OADS,/arxiv_data1/oa_pdf/33/d5/amep-4-201.PMC3805182.pdf
"In addition, the W(e) Learn framework has embedded flexibility to guide the design  and evaluation of learning programs.16 Since publication, W(e)Learn has been used in numer - ous studies.16,17–20 The W(e)Learn framework and the com - panion tools have been used jointly to develop and evaluate  programs.19 For example, in Canada, they have been used in  provincial level eLearning programs, including ePhysician  Health ( http://ephysicianhealth.co m) and eWorkplace Health  (http://eworkplacehealth.co m).",Non-OADS,/arxiv_data1/oa_pdf/33/d5/amep-4-201.PMC3805182.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/33/d5/amep-4-201.PMC3805182.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/d5/amep-4-201.PMC3805182.pdf
Available from: http://www.irrodl.org/index.php/ irrodl/article/view/237/32 1.,Non-OADS,/arxiv_data1/oa_pdf/33/d5/amep-4-201.PMC3805182.pdf
Available  from: http://necsi.org/events/iccs6/viewpaper.php?i d=221.,OADS,/arxiv_data1/oa_pdf/33/d5/amep-4-201.PMC3805182.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/42/amep-4-217.PMC3805183.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 217–222Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  217OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S4621 4Effect of year of study on stress levels   in male undergraduate dental students Abdullah M Alzahem1 henk T Van der Molen2 Benjamin J De Boer3 1Advanced Education in general  Dentistry (AE gD) residency  Program, King Abdullah international  Medical research center/King  saud bin Abdulaziz University for  health sciences/ national guard  health Affairs, riyadh, saudi Arabia;   2institute of Psychology, Faculty of  social sciences, Erasmus University,   rotterdam, The netherlands; 3clinical  Psychology, Princess nora University,   riyadh, saudi Arabia correspondence: Abdullah M Alzahem   King Abdullah international Medical  research center/King saud bin Abdulaziz  University for health sciences/national  guard health Affairs, central region,  PO Box 22490, Mail code 1243, riyadh  11426, saudi Arabia   Tel +966 1801 1111   Fax +966 1801 4010   Email zahem@yahoo.co mObjective:  Stress among dental students can be a significant threat, resulting in physical and/or  mental illness, and have a negative effect on students’ performance and the professional practice  of dentistry.",Non-OADS,/arxiv_data1/oa_pdf/ea/42/amep-4-217.PMC3805183.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/ea/42/amep-4-217.PMC3805183.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/42/amep-4-217.PMC3805183.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/99/amep-4-223.PMC3805184.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 223–226Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  223OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5331 9correlation of psychomotor skills and didactic  performance among dental students in saudi Arabia Ahmed r Afify1 Khalid h Zawawi1 hisham i Othman2 Ayman A Al-Dharrab3 1Department of Preventive Dental  sciences, 2Department of Basic Oral  and clinical sciences, 3Department of  Oral and Maxillofacial rehabilitation,   Faculty of Dentistry, King Abdulaziz  University, Jeddah, saudi Arabia correspondence: Khalid h Zawawi   Department of Preventive Dental science,   Faculty of Dentistry, King Abdulaziz   University, PO Box 80209, Jeddah,   21589, saudi Arabia   Tel +966 2 640 2000 ext 20388   Fax +966 2 640 3316   Email kzawawi@kau.edu.s aObjectives:  The objective of this study is to investigate the correlation between the  psychomotor  skills and the academic performance of dental students.",Non-OADS,/arxiv_data1/oa_pdf/87/99/amep-4-223.PMC3805184.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/87/99/amep-4-223.PMC3805184.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/99/amep-4-223.PMC3805184.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/ac/copd-8-501.PMC3805248.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 501–508International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  501OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S4961 5Efficacy and safety of QVA149 compared   to the concurrent administration of its   monocomponents indacaterol   and glycopyrronium: the BEACON study ronald Dahl1 Dalal Jadayel2 Vijay KT Alagappan3 hungta Chen3 Donald Banerji3 1Department of Dermatology,   Allergy Centre, Odense University  Hospital, Odense, Denmark; 2novartis  Horsham Research Centre, Horsham,   UK; 3novartis Pharmaceuticals  Corporation, East Hanover, NJ, USA Correspondence: ronald Dahl   Department of Dermatology, Allergy  Centre, Odense University Hospital, Sdr  Boulevard 29, 5000 Odense C, Denmark   T el +45 6541 3620   email ronadahl@rm.d kIntroduction:  The BEACON study evaluated the efficacy and safety of QV A149, a once-daily  dual bronchodilator containing a fixed-dose combination of the long-acting β2-agonist (LABA)  indacaterol and long-acting muscarinic antagonist (LAMA) glycopyrronium (NV A237), in  development for the treatment of patients with chronic obstructive pulmonary disease (COPD),  compared with the free-dose concurrent administration of indacaterol plus glycopyrronium  (IND +GL Y).",Non-OADS,/arxiv_data1/oa_pdf/01/ac/copd-8-501.PMC3805248.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/01/ac/copd-8-501.PMC3805248.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/ac/copd-8-501.PMC3805248.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT0152963 2.,Non-OADS,/arxiv_data1/oa_pdf/01/ac/copd-8-501.PMC3805248.pdf
Available from:  http://www.clinicaltrials.gov/ct2/show/NCT00570778?ter m=NCT0057 0778&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/01/ac/copd-8-501.PMC3805248.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial   re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/1d/glt094.PMC3805300.pdf
"OncoImmunology 2013; 2:e25419; http://dx.doi.org/10.4161/onci.25419with progressive (e.g., HSB-2 cells) or  refractory (e.g., Nalm-6, DG-75, CTV-1, and CTV-2 cells) leukemia.",Non-OADS,/arxiv_data1/oa_pdf/15/67/onci-2-e25419.PMC3805632.pdf
Leuk Lymphoma 2007; 48:1320-2; PMID:17613760;  http://dx.doi.org/10.1080/10428190701361844 2.,Non-OADS,/arxiv_data1/oa_pdf/15/67/onci-2-e25419.PMC3805632.pdf
Int J Environ  Res Public Health 2012; 9:2636-57; PMID:23066388;  http://dx.doi.org/10.3390/ijerph9082636 3.,OADS,/arxiv_data1/oa_pdf/15/67/onci-2-e25419.PMC3805632.pdf
Blood 2004; 104:822-8;  PMID:15090454; http://dx.doi.org/10.1182/blood- 2003-11-39384.,Non-OADS,/arxiv_data1/oa_pdf/15/67/onci-2-e25419.PMC3805632.pdf
Br Med Bull 2006; 79-80:153-70; PMID:17277075; http://dx.doi.org/10.1093/bmb/ ldl020 5.,Non-OADS,/arxiv_data1/oa_pdf/15/67/onci-2-e25419.PMC3805632.pdf
PLoS One 2011; 6:e26517;  PMID:22110587; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/15/67/onci-2-e25419.PMC3805632.pdf
Gastroenterology 2008; 134:988-97; PMID:18395080;  http://dx.doi.org/10.1053/j.gastro.2008.01.0157.,Non-OADS,/arxiv_data1/oa_pdf/15/67/onci-2-e25419.PMC3805632.pdf
Br J Cancer  2005; 92:1746-53; PMID:15856045; http://dx.doi.org/10.1038/sj.bjc.6602534,Non-OADS,/arxiv_data1/oa_pdf/15/67/onci-2-e25419.PMC3805632.pdf
"OncoImmunology 2013; 2:e25236;  http://dx.doi.org/10.4161/onci.25236attracted by therapeutic strategies aimed  at activating effector and memory T cells, as the secretion of their cytotoxic granules can directly kill malignant cells.",Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
J Exp Med 2012; 209:201- 9; PMID:22330682; http://dx.doi.org/10.1084/ jem.20112275 2.,Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
Nat Rev Cancer  2011; 11:805-12; PMID:22020206; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
Ann N Y Acad  Sci 2013; 1284:v-vii; PMID:23651200; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
Cancer Res  2013; 73:2381-8; PMID:23580578; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
Br J Cancer 2013; 108:1560-5; PMID:23511566; http://dx.doi.org/10.1038/ bjc.2013.117 6.,Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
Am J Respir Crit Care Med  2010; 181:1383-90; PMID:20167848; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
BMC Cancer 2012; 12:580;  PMID:23217146; http://dx.doi.org/10.1186/1471- 2407-12-5808.,Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
Nat Rev Cancer 2013; 13:365-76; PMID:23535846; http://dx.doi.org/10.1038/nrc3498 9.,Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
J T ransl Med 2012; 10:205; PMID:23034130; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
Nat Biotechnol 2012; 30:639-47; PMID:22781693; http://dx.doi.org/10.1038/nbt.2283,Non-OADS,/arxiv_data1/oa_pdf/da/48/onci-2-e25236.PMC3805634.pdf
OncoImmunology 2013; 2:e25125; http://dx.doi.org/10.4161/onci.25125metastatic potential as compared with  those developing from parental TM40D cells.,Non-OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
Cell 1996; 84:443-50; PMID:8608598; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
Cancer Res 2007; 67:1254-61; PMID:17283162; http://dx.doi.org/10.1158/0008- 5472.CAN-06-24393.,Non-OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
Breast Cancer Res 2012; 14:R16;  PMID:22264274; http://dx.doi.org/10.1186/bcr3100 4.,Non-OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
Gynecol Oncol  2007; 105:418-26; PMID:17306351; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
Clin Exp Metastasis  2010; 27:133-40; PMID:20180146; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
Proc Natl Acad Sci U S A 2008; 105:18490- 5; PMID:19001271; http://dx.doi.org/10.1073/ pnas.0809242105,Non-OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
T rends Immunol 2011; 32:19- 25; PMID:21067974; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
Clin Cancer Res 2011; 17:6118-24;  PMID:21705455; http://dx.doi.org/10.1158/1078- 0432.CCR-11-04827.,Non-OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
J Biol Chem 2013; 288:11676- 88; PMID:23486482; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
Genome Biol 2007; 8:R191;  PMID:17868458; http://dx.doi.org/10.1186/gb-2007-8-9-r191,OADS,/arxiv_data1/oa_pdf/06/3b/onci-2-e25125.PMC3805635.pdf
"OncoImmunology 2013; 2:e25237;  http://dx.doi.org/10.4161/onci.25237immunodeficiency3 and graft- vs. -host  disease.4 With this in mind, we per - formed a multiplex characterization of  B-cell subtypes in the neoplastic lesions, non-malignant tissues, lymph nodes and peripheral blood of patients affected by various solid tumors.",Non-OADS,/arxiv_data1/oa_pdf/88/46/onci-2-e25237.PMC3805648.pdf
Oncoimmunology 2012; 1:1623-5; PMID:23264915;  http://dx.doi.org/10.4161/onci.21650 2.,Non-OADS,/arxiv_data1/oa_pdf/88/46/onci-2-e25237.PMC3805648.pdf
PLoS  One 2012; 7:e32639; PMID:22393427; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/46/onci-2-e25237.PMC3805648.pdf
Cytometry  B Clin Cytom 2008; 74:261-71; PMID:18561200;  http://dx.doi.org/10.1002/cyto.b.204324.,Non-OADS,/arxiv_data1/oa_pdf/88/46/onci-2-e25237.PMC3805648.pdf
J Immunol 2013; 190:5847-55; PMID:23630345;  http://dx.doi.org/10.4049/jimmunol.1203279 6.,Non-OADS,/arxiv_data1/oa_pdf/88/46/onci-2-e25237.PMC3805648.pdf
Annu Rev Immunol  2006; 24:467-96; PMID:16551256; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/88/46/onci-2-e25237.PMC3805648.pdf
Ann Surg Oncol 2010; 17:1747-57; PMID:20119674;  http://dx.doi.org/10.1245/s10434-010-0920-8 9.,Non-OADS,/arxiv_data1/oa_pdf/88/46/onci-2-e25237.PMC3805648.pdf
Eur Urol 2010; 58:105-11; PMID:19766386;  http://dx.doi.org/10.1016/j.eururo.2009.09.026,OADS,/arxiv_data1/oa_pdf/88/46/onci-2-e25237.PMC3805648.pdf
Tissue Barriers  2013; 1:e24894; http://dx.doi.org/10.4161/tisb.24894;   http://dx.doi.org/10.4161/tisb.24894Tight junctions of the pancreatic duct are essential regulators  of physiologic secretion of the pancreas and disruption of  the pancreatic ductal barrier is known to contribute to the  pathogenesis of pancreatitis and progression of pancreatic  cancer.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
FEBS Lett  2000; 476:258-61; PMID:10913624; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Anaerobe 2004; 10:107-14;  PMID:16701507; http://dx.doi.org/10.1016/j.anaer - obe.2003.11.004 35.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Biol Chem  1997; 272:26652-8; PMID:9334247; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Science  1998; 279:349-52; PMID:9454332; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Curr  Biol 1998; 8:279-82; PMID:9501072; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Cell Tissue Res  2007; 330:63-74; PMID:17701057; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Cell Biol 1993; 123:293- 302; PMID:8408213; http://dx.doi.org/10.1083/ jcb.123.2.293 40.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Biosci Rep  2003; 23:87-102; PMID:14570379; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
BMC Cell Biol 2009; 10:36;  PMID:19422706; http://dx.doi.org/10.1186/1471- 2121-10-36 44.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Cell Biochem 2011; 112:1761- 72; PMID:21381080; http://dx.doi.org/10.1002/ jcb.23095 46.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Biol Chem 2006; 281:38941-50; PMID:17060315;  http://dx.doi.org/10.1074/jbc.M60838920018.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Gastroenterol 2000; 35:758- 67; PMID:11063220; http://dx.doi.org/10.1007/ s005350070035 19.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Med  Electron Microsc 2002; 35:146-52; PMID:12353135;  http://dx.doi.org/10.1007/s007950200018 20.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Br J Surg 1989; 76:859- 62; PMID:2475200; http://dx.doi.org/10.1002/ bjs.1800760832 21.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Gastroenterology 1995; 108:1863-72;  PMID:7539388; http://dx.doi.org/10.1016/0016- 5085(95)90151-5 23.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Pancreas  2004; 28:181-90; PMID:15028951; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Am  J Surg 1998; 176:53-8; PMID:9683134; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Mol Histol 2004; 35:355- 62; PMID:15503809; http://dx.doi.org/10.1023/ B:HIJO.0000039838.56131.02 26.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Gastroenterology 2001; 121:678- 84; PMID:11522752; http://dx.doi.org/10.1053/ gast.2001.27124 28.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Am J Surg Pathol  2008; 32:188-96; PMID:18223320; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Dev Dyn  2012; 241:583-94; PMID:22275141; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
FEBS Lett 2011; 585:606-12;  PMID:21276448; http://dx.doi.org/10.1016/j.febs - let.2011.01.028 31.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Nature  2007; 446:801-5; PMID:17325668; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Annu Rev Physiol 2006; 68:403- 29; PMID:16460278; http://dx.doi.org/10.1146/ annurev.physiol.68.040104.131404References 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Int J  Biochem Cell Biol 2005; 37:504-10; PMID:15618005;  http://dx.doi.org/10.1016/j.biocel.2004.07.010 2.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Cell Biol 1993; 123:1631-3; PMID:8276885;  http://dx.doi.org/10.1083/jcb.123.6.1631 3.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Annu Rev Physiol 1998; 60:161-77;  PMID:9558459; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Nat Rev Mol Cell Biol 2003; 4:225- 36; PMID:12612641; http://dx.doi.org/10.1038/ nrm1055 7.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Nat Rev Mol Cell Biol  2001; 2:285-93; PMID:11283726; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Med Electron Microsc 2003; 36:147-56;  PMID:14505058; http://dx.doi.org/10.1007/s00795- 003-0219-y 9.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Am J Physiol Cell Physiol  2004; 286:C1213-28; PMID:15151915; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Biochim Biophys Acta 2008; 1778:729-56;  PMID:17950242; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Virchows Arch 2007; 450:549-57; PMID:17429687;  http://dx.doi.org/10.1007/s00428-007-0406-7 13.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Am J Pathol  2010; 177:698-712; PMID:20566751; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Arch Histol Jpn 1979; 42:141-52; PMID:464749;  http://dx.doi.org/10.1679/aohc1950.42.141 15.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Pancreas 1989; 4:472-85; PMID:2762275;  http://dx.doi.org/10.1097/00006676-198908000- 00013 16.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Cell Biol 1963; 17:375- 412; PMID:13944428; http://dx.doi.org/10.1083/ jcb.17.2.375 17.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Pflugers  Arch 1977; 367:265-70; PMID:556848; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Cancer Res 2006; 66:10024-31;  PMID:17047065; http://dx.doi.org/10.1158/0008- 5472.CAN-06-0136 69.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Cancer Res 2008; 68:5031-9;  PMID:18593901; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6332 71.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Clin Invest 2008; 118:3943- 53; PMID:19033664; http://dx.doi.org/10.1172/ JCI37156 72.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Cancer Sci 2013; 104:337-44; PMID:23237571;  http://dx.doi.org/10.1111/cas.12080 74.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Exp Cell Res 2011; 317:2288- 98; PMID:21763689; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
T rends Pharmacol  Sci 2010; 31:8-14; PMID:19969380; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Cell Cycle  2009; 8:2110-21; PMID:19502798; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Cell Physiol 2010; 225:720-33; PMID:20533305;  http://dx.doi.org/10.1002/jcp.22273 61.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
J Cell Biol  2005; 171:939-45; PMID:16365161; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Mol Biol Cell 2009; 20:3713-24;  PMID:19535456; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Histopathology 2012;  60(6B):E76-86; PMID:22394074; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Mol Biol Cell  2010; 21:1200-13; PMID:20164257; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Am J Physiol Cell Physiol  2009; 297:C775-87; PMID:19605737; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Pharmacol  Res 2010; 61:489-98; PMID:20227502; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Cancer T reat Rev 2009; 35:1- 8; PMID:18778896; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Toll-like receptor  2 enhances ZO-1-associated intestinal epithelial bar - rier integrity via protein kinase C. Gastroenterology  2004; 127:224-38; PMID:15236188; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Carcinogenesis  2009; 30:1927-31; PMID:19710177; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Cell Tissue Res 2011; 346:369-81; PMID:22160590;  http://dx.doi.org/10.1007/s00441-011-1287-2 55.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Carcinogenesis 2013; PMID:23389293; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
Am  J Physiol Gastrointest Liver Physiol 2008; 294:G899- 905; PMID:18239055; http://dx.doi.org/10.1152/ ajpgi.00411.2007,Non-OADS,/arxiv_data1/oa_pdf/c4/16/tisb-1-e24894.PMC3805649.pdf
"OncoImmunology 2013; 2:e25375; http://dx.doi.org/10.4161/onci.25375function as it reduces the number and  function of circulating DCs, promotes the generation of Tregs, and inhibits cytotoxic T lymphocytes (CTLs).",Non-OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
Nat Med 1997;  3:558-61; PMID:9142127; http://dx.doi.org/10.1038/ nm0597-558 2.,Non-OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
Oncoimmunology 2013; 2:e24437; PMID:23762810;  http://dx.doi.org/10.4161/onci.24437 3.,Non-OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
Clin Dev Immunol 2009;  2009:657369; PMID:20182533; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
PLoS One 2013; 8:e59280;  PMID:23555011; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
Clin Cancer Res 2009; 15:6560-9;  PMID:19861451; http://dx.doi.org/10.1158/1078- 0432.CCR-09-10666.,Non-OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
Clin Cancer Res 2009; 15:6551-9;  PMID:19861464; http://dx.doi.org/10.1158/1078- 0432.CCR-09-1067 7.,Non-OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
Cancer Immunol  Immunother 2012; 61:425-31; PMID:22193988;  http://dx.doi.org/10.1007/s00262-011-1188-y,Non-OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
Nat Rev Cancer 2012; 12:252- 64; PMID:22437870; http://dx.doi.org/10.1038/ nrc32398.,Non-OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
PLoS  One 2013; 8:e63498; PMID:23717436; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bd/af/onci-2-e25375.PMC3805650.pdf
"OncoImmunology 2013; 2:e25218; http://dx.doi.org/10.4161/onci.25218were found to suppress autologous T-cell  proliferation independently of each other, thus constituting fully functional human MDSC.",Non-OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
Annu Rev Immunol 2006; 24:175-208;  PMID:16551247; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
Semin Cancer Biol  2012; 22:319-26; PMID:22349515; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
Curr T reat Options Oncol  2013; 14:280-92; PMID:23420410; http://dx.doi.org/10.1007/s11864-013-0226-8 6.,Non-OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
J Exp Med 2006; 203:1651-6; PMID:16801397; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
J Immunol 2010; 185:2273-84;  PMID:20644162; http://dx.doi.org/10.4049/jimmu- nol.1000901 8.,Non-OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
Clin Cancer Res 2012; 18:1386-94;  PMID:22156613; http://dx.doi.org/10.1158/1078- 0432.CCR-11-24799.,Non-OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
Cancer Res  2010; 70:5213-9; PMID:20551059; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
N Engl J Med 2013; 368:1365- 6; PMID:23550685; http://dx.doi.org/10.1056/ NEJMc1302338,Non-OADS,/arxiv_data1/oa_pdf/de/58/onci-2-e25218.PMC3805652.pdf
"OncoImmunology 2013; 2:e25220;  http://dx.doi.org/10.4161/onci.25220Like T cells, NK cells can be geneti - cally modified to express chimeric anti - gen receptors (CARs), allowing them to  selectively recognize tumor-associated cell surface antigens and hence increas - ing their specificity and antineoplastic activity.",Non-OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
Nat Rev Immunol  2008; 8:713-25; PMID:19172692; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
Annu Rev Immunol 2011; 29:235-71; PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-1013243.,Non-OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
Lancet 2000; 356:1795-9;  PMID:11117911; http://dx.doi.org/10.1016/S0140- 6736(00)03231-1,OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
PLoS One 2013; 8:e61267;  PMID:23573299; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
Selective induc-tion of cancer cell death by targeted granzyme B.  Antibodies 2013; 2:130-51; http://dx.doi.org/10.3390/ antib20101307.,Non-OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
Cancer Immunol  Immunother 2012; 61:1451-61; PMID:22310931;  http://dx.doi.org/10.1007/s00262-012-1212-x 8.,Non-OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
J Innate Immun 2011;  3:355-64; PMID:21502747; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
Nat Rev Immunol 2012; 12:239-52;  PMID:22437937; http://dx.doi.org/10.1038/nri3174 5.,Non-OADS,/arxiv_data1/oa_pdf/ba/2f/onci-2-e25220.PMC3805653.pdf
OncoImmunology 2013; 2:e25219;  http://dx.doi.org/10.4161/onci.25219the induction or ectopic overexpression  of MICA in glioma cells enhances NK and T cell-mediated antitumor responses in vitro and delays GBM growth in vivo.,Non-OADS,/arxiv_data1/oa_pdf/e4/c6/onci-2-e25219.PMC3805657.pdf
Brain  2006; 129:2416-25; PMID:16891318; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/c6/onci-2-e25219.PMC3805657.pdf
Handb Exp Pharmacol 2011; 206:13-37;  PMID:21879444; http://dx.doi.org/10.1007/978-3- 642-21631-2_2 4.,Non-OADS,/arxiv_data1/oa_pdf/e4/c6/onci-2-e25219.PMC3805657.pdf
Mol Oncol 2007; 1:19- 25; PMID:19383284; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e4/c6/onci-2-e25219.PMC3805657.pdf
Cancer Res 2005; 65:6321-9; PMID:16024634;  http://dx.doi.org/10.1158/0008-5472.CAN-04-4252 6.,Non-OADS,/arxiv_data1/oa_pdf/e4/c6/onci-2-e25219.PMC3805657.pdf
J Clin Oncol  2009; 27:2052-8; PMID:19307505; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/c6/onci-2-e25219.PMC3805657.pdf
PLoS One 2012; 7:e30815; PMID:22303460;  http://dx.doi.org/10.1371/journal.pone.0030815,Non-OADS,/arxiv_data1/oa_pdf/e4/c6/onci-2-e25219.PMC3805657.pdf
Tissue Barriers 2013; 1:e25585; http://dx.doi.org/10.4161/ tisb.25585Scanning Ion Conductance Microscopy (SICM) has been  developed originally for high-resolution imaging of  topographic features.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Annu Rev Physiol 2006; 68:403- 29; PMID:16460278; http://dx.doi.org/10.1146/ annurev.physiol.68.040104.131404 2.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Nat Rev Mol Cell Biol  2001; 2:285-93; PMID:11283726; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Cell Biol 1963; 17:375- 412; PMID:13944428; http://dx.doi.org/10.1083/ jcb.17.2.375 5.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Anal Chem 2013; 85:3621-8; PMID:23421780;  http://dx.doi.org/10.1021/ac303441n6.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Acta  Physiol Scand 1949; 19:43-56; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Acta Physiol Scand  1951; 23:110-27; PMID:14868510; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Clin Invest 2001; 107:1319-27; PMID:11375422;  http://dx.doi.org/10.1172/JCI12464 9.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Biol Chem 2003; 278:17350-9;  PMID:12615928; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Biol Chem  2006; 281:36117-23; PMID:17018523; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Pflugers  Arch 1985; 405:400-2; PMID:4080518; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Sensors (Basel) 2012; 12:14983-5008;  PMID:23202197; http://dx.doi.org/10.3390/ s121114983 44.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
ACS Nano  2011; 5:8404-11; PMID:21923184; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Anal Chem 2012; 84:3003- 9; PMID:22390616; http://dx.doi.org/10.1021/ ac300257q 46.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Membr Biol 1974; 19:357- 80; PMID:4549221; http://dx.doi.org/10.1007/ BF01869986 47.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Biophys J 2000; 78:2675-9;  PMID:10777763; http://dx.doi.org/10.1016/S0006- 3495(00)76811-1 49.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Cell Sci  2008; 121:298-305; PMID:18198187; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Clin Invest 2006; 116:2682- 94; PMID:17016558; http://dx.doi.org/10.1172/ JCI29218 54.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Cell Mol Life Sci 2011; 68:3903-18;  PMID:21533891; http://dx.doi.org/10.1007/s00018- 011-0680-z29.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Mucosal Immunol 2008;  1(Suppl 1):S58-61; PMID:19079233; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Membr Biol 1980;  53:19-32; PMID:7373646; http://dx.doi.org/10.1007/ BF01871169 32.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Phys Chem Chem Phys  2005; 7:2859-66; PMID:16189604; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Appl Phys 2009; 105:094905;  http://dx.doi.org/10.1063/1.3122007 38.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Anal Chem 2009; 81:4482-92; PMID:19405486;  http://dx.doi.org/10.1021/ac900376w 39.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Angew Chem Int Ed Engl  2006; 45:2212-6; PMID:16506257; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Biophys J 1997; 73:653-8; PMID:9251784;  http://dx.doi.org/10.1016/S0006-3495(97)78100-1 41.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Biophys J  2001; 81:1759-64; PMID:11509385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Nat Methods  2009; 6:279-81; PMID:19252505; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Biochem Biophys Res Commun 2009; 378:45-50;  PMID:19000657; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Biophys J 2009; 97:2202- 11; PMID:19843452; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Biomaterials 2013; 34:275- 82; PMID:23069717; http://dx.doi.org/10.1016/j.bio - materials.2012.09.051 20.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Membr  Biol 1972; 8:259-301; PMID:5084117; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Ann N Y Acad  Sci 1998; 859:295-9; PMID:10049237; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
J Physiol 2002; 545:485-99;  PMID:12456828; http://dx.doi.org/10.1113/jphysi - ol.2002.031161 27.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
AIDS 2002;  16:983-91; PMID:11953464; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
Gastroenterology 2001; 121:1320- 8; PMID:11729111; http://dx.doi.org/10.1053/ gast.2001.29694,Non-OADS,/arxiv_data1/oa_pdf/ff/d5/tisb-1-e25585.PMC3805658.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c7/54/ijbsv09p0853.PMC3805834.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/71/af/ijbsv09p0863.PMC3805894.pdf
"quinquefasciatus genome  sequence [http://cquinquefasciatus.vectorbase.org/] (Yang and Liu, 2011).",OADS,/arxiv_data1/oa_pdf/71/af/ijbsv09p0863.PMC3805894.pdf
"b The annot a- tion of the Culex P450 genes from http://drnelson.utmem.edu/CytochromeP450.html (Yang and Liu, 2011).",OADS,/arxiv_data1/oa_pdf/71/af/ijbsv09p0863.PMC3805894.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/36/ijbsv09p0872.PMC3805895.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/fc/ijbsv09p0887.PMC3805896.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/af/13/ijbsv09p0907.PMC3805897.pdf
"Further  information about this platform is also available in the  ‘Array Express’ database (accession number   A-AFFY -189, http://www.ebi.ac.uk/arrayexpress/   arrays/A -AFFY -189/ ).",OADS,/arxiv_data1/oa_pdf/af/13/ijbsv09p0907.PMC3805897.pdf
Microarray data  is MIAME -compliant and was deposited  in the dat a- base of the National Center for Biotechnology Info r- mation Gene Expression Omnibus http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/af/13/ijbsv09p0907.PMC3805897.pdf
http://www.ingenuity.com .,Non-OADS,/arxiv_data1/oa_pdf/af/13/ijbsv09p0907.PMC3805897.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b5/f9/ijbsv09p0917.PMC3805898.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7b/87/ijbsv09p0947.PMC3805899.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/73/ijbsv09p0948.PMC3805900.pdf
"Information on isoforms c, d and e were obtained from the literature [1 -4, 39-44], while domain information for isoforms “ a” and “b” was obtained using  the NCBI “conserved dom ain search” function at:  http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi.",OADS,/arxiv_data1/oa_pdf/9c/73/ijbsv09p0948.PMC3805900.pdf
This analysis was  performed using William Pearson’s l align program  with Huang and Miller’s algorithm which can be found at http://www.ch.embnet.org/software/,OADS,/arxiv_data1/oa_pdf/9c/73/ijbsv09p0948.PMC3805900.pdf
"William Pearson’s lalign program was used with default  settings, which can be found at http://www.ch.embnet.org/   software/LALIGN_form.html.",OADS,/arxiv_data1/oa_pdf/9c/73/ijbsv09p0948.PMC3805900.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4b/81/ijbsv09p0960.PMC3805901.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ba/c9/ijbsv09p0966.PMC3805902.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/69/0d/ijbsv09p0989.PMC3805903.pdf
BLAST  search es were   performed online at NCBI BLAST (http://blast.ncbi.,OADS,/arxiv_data1/oa_pdf/69/0d/ijbsv09p0989.PMC3805903.pdf
The theoretic  molecular weight and isoelectric point (pI) of deduced  amino acid sequences were calculated by the ExPASy  Proteomics Server (http://cn.expasy.org/tools/   pi_tool.html).,OADS,/arxiv_data1/oa_pdf/69/0d/ijbsv09p0989.PMC3805903.pdf
"A ll gene specific  primers were designed against regions where no a l- ternative splicing exons were found ( Supplementary  Material: Table S1), using Primer -BLAST  (http://www.ncbi.nlm.nih.gov/tools/primer -blast/   index.cgi?LINK_LOC=BlastHome ).The specificity of  each set of primers was validated by melting profile.",OADS,/arxiv_data1/oa_pdf/69/0d/ijbsv09p0989.PMC3805903.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/88/ijbsv09p1004.PMC3805904.pdf
"To find AMP genes, a local BLASTN search was pe r- formed using sequences of known AMP from D.  melanogaster  and M. sexta  as queri es  (http://cegg.unige.ch/insecta/immunodb/) [14].",OADS,/arxiv_data1/oa_pdf/d2/88/ijbsv09p1004.PMC3805904.pdf
The obtained sequencing components with the P-value lower than 0.01 were retrieved and assembled  into contigs in CAP3 ( http://pbil.univ -lyon1.fr/   cap3.php).,OADS,/arxiv_data1/oa_pdf/d2/88/ijbsv09p1004.PMC3805904.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgJ Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/db/ce/jgo-24-291.PMC3805906.pdf
4:291-292 http://dx.doi.org/10.3802/jgo.2013.24.4.291,Non-OADS,/arxiv_data1/oa_pdf/db/ce/jgo-24-291.PMC3805906.pdf
Byoung-Gie Kim http://dx.doi.org/10.3802/jgo.2013.24.4.291 292  www.ejgo.org rence [12].,OADS,/arxiv_data1/oa_pdf/db/ce/jgo-24-291.PMC3805906.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgJ Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/92/a2/jgo-24-293.PMC3805907.pdf
4:293-294 http://dx.doi.org/10.3802/jgo.2013.24.4.293,Non-OADS,/arxiv_data1/oa_pdf/92/a2/jgo-24-293.PMC3805907.pdf
Lynette Denny http://dx.doi.org/10.3802/jgo.2013.24.4.293 294  www.ejgo.org women with advanced disease.,Non-OADS,/arxiv_data1/oa_pdf/92/a2/jgo-24-293.PMC3805907.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgCervical cancer is the most common cancer in developing world and 80% of global burden is reported from these nations.",Non-OADS,/arxiv_data1/oa_pdf/9a/f6/jgo-24-295.PMC3805908.pdf
4:295-297 http://dx.doi.org/10.3802/jgo.2013.24.4.295,Non-OADS,/arxiv_data1/oa_pdf/9a/f6/jgo-24-295.PMC3805908.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.295 296  www.ejgo.org tion of cervical cancer and is gaining wide popularity around  the world.,Non-OADS,/arxiv_data1/oa_pdf/9a/f6/jgo-24-295.PMC3805908.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To investigate the recent incidence of and trends in cervical, endometrial, and ovarian cancer in Korean females.",Non-OADS,/arxiv_data1/oa_pdf/8f/a9/jgo-24-298.PMC3805909.pdf
4:298-302 http://dx.doi.org/10.3802/jgo.2013.24.4.298,Non-OADS,/arxiv_data1/oa_pdf/8f/a9/jgo-24-298.PMC3805909.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.298 300  www.ejgo.org and ovarian cancer has increased.,Non-OADS,/arxiv_data1/oa_pdf/8f/a9/jgo-24-298.PMC3805909.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.298 302  www.ejgo.org REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/a9/jgo-24-298.PMC3805909.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The aim of this study was to evaluate the learning curve and perioperative outcomes of robot-assisted laparoscopic  procedure for cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/42/2c/jgo-24-303.PMC3805910.pdf
4:303-312 http://dx.doi.org/10.3802/jgo.2013.24.4.303,Non-OADS,/arxiv_data1/oa_pdf/42/2c/jgo-24-303.PMC3805910.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.303 304  www.ejgo.org straight stick laparoscopy.,Non-OADS,/arxiv_data1/oa_pdf/42/2c/jgo-24-303.PMC3805910.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.303 306  www.ejgo.org conventional straight stick laparoscopy or laparotomy.,Non-OADS,/arxiv_data1/oa_pdf/42/2c/jgo-24-303.PMC3805910.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.303 308  www.ejgo.org in the 59th patient (phase 2).,Non-OADS,/arxiv_data1/oa_pdf/42/2c/jgo-24-303.PMC3805910.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.303 310  www.ejgo.org assisted on various cases.,Non-OADS,/arxiv_data1/oa_pdf/42/2c/jgo-24-303.PMC3805910.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.303 312  www.ejgo.org gynaecological surgery-establishing training criteria; minimizing  operative time and blood loss.,Non-OADS,/arxiv_data1/oa_pdf/42/2c/jgo-24-303.PMC3805910.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The aim of the present study was to assess prognostic factors for patients with locally advanced cervical cancer  treated with radiotherapy as the primary treatment and to assess the posttreatment cut-off levels of squamous cell carcinoma  antigen (SCC-Ag) to predict three-year overall survival (OS) rates.",Non-OADS,/arxiv_data1/oa_pdf/20/3c/jgo-24-313.PMC3805911.pdf
4:313-320 http://dx.doi.org/10.3802/jgo.2013.24.4.313,Non-OADS,/arxiv_data1/oa_pdf/20/3c/jgo-24-313.PMC3805911.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.313 314  www.ejgo.org tumor characteristics.,Non-OADS,/arxiv_data1/oa_pdf/20/3c/jgo-24-313.PMC3805911.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.313 316  www.ejgo.org stage IIB-IVA cervical cancer.,Non-OADS,/arxiv_data1/oa_pdf/20/3c/jgo-24-313.PMC3805911.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.313 318  www.ejgo.org Fifty-five patients of 116 patients (47.4%) were diagnosed  with recurrence.,Non-OADS,/arxiv_data1/oa_pdf/20/3c/jgo-24-313.PMC3805911.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.313 320  www.ejgo.org therapy for locally advanced cervical cancer.,Non-OADS,/arxiv_data1/oa_pdf/20/3c/jgo-24-313.PMC3805911.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To investigate the utility of serum squamous cell carcinoma antigen (SCC-Ag) levels upon the diagnosis of recurrent  cervical cancer for decision making in patient management.",Non-OADS,/arxiv_data1/oa_pdf/1a/f3/jgo-24-321.PMC3805912.pdf
4:321-329 http://dx.doi.org/10.3802/jgo.2013.24.4.321,Non-OADS,/arxiv_data1/oa_pdf/1a/f3/jgo-24-321.PMC3805912.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.321 322  www.ejgo.org tigated in several studies [8-11].,Non-OADS,/arxiv_data1/oa_pdf/1a/f3/jgo-24-321.PMC3805912.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.321 324  www.ejgo.org Fig.,OADS,/arxiv_data1/oa_pdf/1a/f3/jgo-24-321.PMC3805912.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.321 326  www.ejgo.org treated with chemotherapy of supportive care alone.,Non-OADS,/arxiv_data1/oa_pdf/1a/f3/jgo-24-321.PMC3805912.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.4.321 328  www.ejgo.org cal cancer aids decision-making regarding salvage treatment  and could allow more accurate, individualized pretreatment  assessments of the benefits that patients will derive from  particular salvage treatments.",Non-OADS,/arxiv_data1/oa_pdf/1a/f3/jgo-24-321.PMC3805912.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To investigate the clinical characteristics of and prognostic factors for primary malignant melanoma of the vagina.",Non-OADS,/arxiv_data1/oa_pdf/ce/fb/jgo-24-330.PMC3805913.pdf
4:330-335 http://dx.doi.org/10.3802/jgo.2013.24.4.330,Non-OADS,/arxiv_data1/oa_pdf/ce/fb/jgo-24-330.PMC3805913.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.330 332  www.ejgo.org stage IV (n=2) primary vaginal melanoma were enrolled in this  study.,Non-OADS,/arxiv_data1/oa_pdf/ce/fb/jgo-24-330.PMC3805913.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.330 334  www.ejgo.org [13].,OADS,/arxiv_data1/oa_pdf/ce/fb/jgo-24-330.PMC3805913.pdf
NOW AVAILABLE ONLINE  at http://www.ejgo.org,Non-OADS,/arxiv_data1/oa_pdf/ce/fb/jgo-24-330.PMC3805913.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To investigate the relationship between serum concentrations of leptin or adiponectin, and endometrial carcinoma  in Chinese women.",Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgo-24-336.PMC3805914.pdf
4:336-341 http://dx.doi.org/10.3802/jgo.2013.24.4.336,Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgo-24-336.PMC3805914.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.4.336 338  www.ejgo.org leptin, insulin, and L/A ratios than controls (mean±SD, cases  vs. controls: leptin 28.8±2.2 ug/L vs. 19.8±1.4 ug/L, p<0.001; L/ A ratios 0.018±0.050 vs. 0.013±0.014, p<0.001; insulin 15.8± 1.4 mU/L, vs. 8.1±0.5 mU/L, p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgo-24-336.PMC3805914.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.336 340  www.ejgo.org velopment of obesity (insulin resistance)-related endometrial  cancer.,Non-OADS,/arxiv_data1/oa_pdf/cc/5e/jgo-24-336.PMC3805914.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To investigate the changes of incidence and prognosis of epithelial ovarian cancer in thirty years in Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/87/74/jgo-24-342.PMC3805915.pdf
4:342-351 http://dx.doi.org/10.3802/jgo.2013.24.4.342,Non-OADS,/arxiv_data1/oa_pdf/87/74/jgo-24-342.PMC3805915.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.342 344  www.ejgo.org Kaplan-Meier method and differences in survival curves were  calculated using the log rank test.,OADS,/arxiv_data1/oa_pdf/87/74/jgo-24-342.PMC3805915.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.4.342 346  www.ejgo.org Our results showed that the distribution of different histo - logical types changed with increasing clear cell type, but de - creasing mucinous type.",OADS,/arxiv_data1/oa_pdf/87/74/jgo-24-342.PMC3805915.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.4.342 348  www.ejgo.org with the age of diagnosis: 1.85 (95% CI, 1.45 to 2.31) for aged  30-39, 2.81 (95% CI, 2.28 to 3.47) for aged 40-49, 3.29 (95%  CI, 2.66 to 4.06) for aged 50-59, 4.74 (95% CI, 3.84 to 5.87) for  aged 60-69, and 7.50 (95% CI, 6.04 to 9.30) for more than 70  years old (test for trend, p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/87/74/jgo-24-342.PMC3805915.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.342 350  www.ejgo.org cologists and benefits of paclitaxel-platinum chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/87/74/jgo-24-342.PMC3805915.pdf
Available from: http://ci5.iarc.fr/CI5plus/ci5plus.htm.,Non-OADS,/arxiv_data1/oa_pdf/87/74/jgo-24-342.PMC3805915.pdf
Available  from: http://www.bhp.doh.gov.tw/BHPNET/Portal/StatisticsShow.,OADS,/arxiv_data1/oa_pdf/87/74/jgo-24-342.PMC3805915.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To evaluate the improvement in prognosis prediction with reassignment of International Federation of Gynecology  and Obstetrics (FIGO) stages for ovarian carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/fb/9d/jgo-24-352.PMC3805916.pdf
4:352-358 http://dx.doi.org/10.3802/jgo.2013.24.4.352,Non-OADS,/arxiv_data1/oa_pdf/fb/9d/jgo-24-352.PMC3805916.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.4.352 354  www.ejgo.org RESULTS The median follow-up period was 45 months (range, 0 to  263 months).",OADS,/arxiv_data1/oa_pdf/fb/9d/jgo-24-352.PMC3805916.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.352 356  www.ejgo.org 4.,Non-OADS,/arxiv_data1/oa_pdf/fb/9d/jgo-24-352.PMC3805916.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.4.352 358  www.ejgo.org prognosis, lower stage, better differentiation and lower regulatory  T cell infiltration.",Non-OADS,/arxiv_data1/oa_pdf/fb/9d/jgo-24-352.PMC3805916.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Intraperitoneal (IP) chemotherapy in women with optimally debulked stage III ovarian cancer has been reported to  prolong overall survival, but has not been widely adopted due to concerns about its toxicity, inconvenience and acceptability to  patients.",Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
4:359-366 http://dx.doi.org/10.3802/jgo.2013.24.4.359,Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.359 360  www.ejgo.org cer present with the epithelial histological subtype (90%) and  advanced disease (International Federation of Gynecology  and Obstetrics [FIGO] stage III or IV) (75%) at initial diagnosis  [2].,Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.359 362  www.ejgo.org required by 23 patients (61%).,Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.359 364  www.ejgo.org Aspects of the design of the three large IP chemotherapy  trials have been criticized and may have contributed to the  slow uptake of IP chemotherapy into routine clinical practice.,Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
Available  from: http://ctep.cancer.gov/highlights/20060105_ovarian.htm.,Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
Available from: http://www.aihw.gov.au/acim-books/.,Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.359 366  www.ejgo.org 15.,Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
Available from:  http:// http://ctep.cancer.gov/protocolDevelopment/electronic_ applications/docs/ctcaev3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/52/47/jgo-24-359.PMC3805917.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Little is known regarding cervical cancer survivors’ employment status, which represents social integration of cancer  survivors as a pivotal domain of long-term quality of life.",Non-OADS,/arxiv_data1/oa_pdf/52/ea/jgo-24-367.PMC3805918.pdf
4:367-375 http://dx.doi.org/10.3802/jgo.2013.24.4.367,Non-OADS,/arxiv_data1/oa_pdf/52/ea/jgo-24-367.PMC3805918.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.367 368  www.ejgo.org burden on society.,Non-OADS,/arxiv_data1/oa_pdf/52/ea/jgo-24-367.PMC3805918.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.367 370  www.ejgo.org Table 2.,OADS,/arxiv_data1/oa_pdf/52/ea/jgo-24-367.PMC3805918.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.4.367 372  www.ejgo.org income, who were previously unemployed, and have other  comorbidities are at a higher risk of unemployment.",Non-OADS,/arxiv_data1/oa_pdf/52/ea/jgo-24-367.PMC3805918.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.367 374  www.ejgo.org for active intervention in the search for employment.,Non-OADS,/arxiv_data1/oa_pdf/52/ea/jgo-24-367.PMC3805918.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgOne of the exciting findings in recent cancer genome studies is the discovery of somatic mutations in several chromatin  remodeling genes.",Non-OADS,/arxiv_data1/oa_pdf/7c/6b/jgo-24-376.PMC3805919.pdf
4:376-381 http://dx.doi.org/10.3802/jgo.2013.24.4.376,Non-OADS,/arxiv_data1/oa_pdf/7c/6b/jgo-24-376.PMC3805919.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.4.376 378  www.ejgo.org In borderline ovarian tumors, loss of ARID1A immunore - activity was found in 33% of endocervical-type mucinous  (sero  mucinous) borderline tumors, 1 (13%) of borderline  endo  metrioid tumor, and none of the borderline serous tumor  and gastrointestinal-type borderline mucinous tumors [36].",Non-OADS,/arxiv_data1/oa_pdf/7c/6b/jgo-24-376.PMC3805919.pdf
http://dx.doi.org/10.3802/jgo.2013.24.4.376 380  www.ejgo.org REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/6b/jgo-24-376.PMC3805919.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/6b/jgo-24-376.PMC3805919.pdf
http://dx.doi.org/10.1038/modpathol.,OADS,/arxiv_data1/oa_pdf/7c/6b/jgo-24-376.PMC3805919.pdf
Available from:  http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/0c/jgo-24-382.PMC3805920.pdf
"Jung-Yun Lee Department of Obstetrics and Gynecology, Seoul National  University College of Medicine, Seoul, Korea http://dx.doi.org/10.3802/jgo.2013.24.4.382Correspondence Correspondence to  Jung-Yun Lee Department of Obstetrics and Gynecology, Seoul National University College  of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea.",Non-OADS,/arxiv_data1/oa_pdf/44/0c/jgo-24-382.PMC3805920.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgJ Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/44/0c/jgo-24-382.PMC3805920.pdf
4:382-383 http://dx.doi.org/10.3802/jgo.2013.24.4.382,Non-OADS,/arxiv_data1/oa_pdf/44/0c/jgo-24-382.PMC3805920.pdf
"Mison Chun1, Hyunsoo Jang2 1Department of Radiation Oncology, Ajou University School  of Medicine, Suwon; 2Department of Radiation Oncology,  Dongguk University School of Medicine, Gyeongju, Korea http://dx.doi.org/10.3802/jgo.2013.24.4.383Correspondence to  Mison Chun Department of Radiation Oncology, Ajou University School of Medicine, 206  World cup-ro, Yeongtong-gu, Suwon 443-721, Korea.",Non-OADS,/arxiv_data1/oa_pdf/44/0c/jgo-24-382.PMC3805920.pdf
"10       http://www.medsci.org  1639  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1639 -1648.  doi: 10.7150/ ijms.6960  Research Paper   Salmonella typhimurium Mediated Delivery of Apoptin in  Human Laryngeal Cancer   Guo- fang Guan1 , Ming Zhao1, Li-ming Liu2, Chun -shun Jin1, Kai Sun1, De-jun Zhang1, Duo -jiao Yu1,  Hong -wei Cao1 , Yan - qing Lu1 and Lian -ji Wen1  1.",Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
"10     http://www.medsci.org  1640  murium  preferentially accumulates in tumours more  than other organs after systemic injection, which r e- duces off -target bacterial toxicity [9, 13] .",Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
"10     http://www.medsci.org  1641  the medium was removed, and 100 μl of dimethy l- sulphoxide wer e added.",Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
10     http://www.medsci.org  1642  as shown in Figure 1C.,Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
"10     http://www.medsci.org  1643  S. typhimurium -mediated Apoptin increases  the activity of caspase -3 and involves Bax,  caspase -9 and Cytochrome c   To elucidate the molecular mechanisms unde r- lying the ST-rC-Apoptin  induced apoptosis, caspase -3  and caspase -8 activities were measured.",OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
10     http://www.medsci.org  1644  also well tolerated and maintained the same pattern  of distribution (Figure 6A).,Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
10     http://www.medsci.org  1645    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
"10     http://www.medsci.org  1646  Discussion   This is the first report utilizing a recom binant  attenuated Salmonella typhimurium  to express  tu- mour -specific apoptosis -inducing gene, Apoptin, in  human laryngeal cancer.",Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
"10     http://www.medsci.org  1647  The investigation of safety and toxicity by histological  staining confirmed that there were no acute hepatic,  lung and kidney adverse effects after systemic injec- tion of 1 x 107 cfu bacteria (Figure 6B).",Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
10     http://www.medsci.org  1648  human laryngeal carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/5b/f3/ijmsv10p1639.PMC3805922.pdf
"10       http://www.medsci.org  1689  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1689 -1697.  doi: 10.7150/ ijms.7292  Research Paper   High-expression o f DJ-1 and Loss of PTEN Associated  with Tumor Metastasis and Correlated with Poor  Prognosis o f Gastric Carcinoma   Yin Li1, Ji Cui1, Chang -hua Zhang1, Dong -jie Yang1, Jian-hui Chen1, Wen- hua Zan1, Bin Li2, Zhi Li2,    Yu-long He1  1.",Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
"10     http://www.medsci.org  1690  invasion and metastasis of this  tumor, but the precise  molecular mechanism remains to be clarified.",Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
"10     http://www.medsci.org  1691  rum for 10 min, the slides  were incubated with a 1:100  dilution of the rabbit anti-human poly clonal DJ-1 an- tibody ( FL-189, Santa  Cruz biotechnology , Dallas, TX,  USA ), or a 1:100 dilution of rabbit  anti-human poly- clonal PTEN  antibody ( Cell Signaling tec hnology,   Beverly, MA, USA) for 60 min,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
10     http://www.medsci.org  1692  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
10     http://www.medsci.org  1693  Table 3 .,Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
10     http://www.medsci.org  1694    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
10     http://www.medsci.org  1695  lesions to invasive carcinoma tissues [14].,Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
10     http://www.medsci.org  1696  the tumor invasiveness.,Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
10     http://www.medsci.org  1697  35.,Non-OADS,/arxiv_data1/oa_pdf/a0/86/ijmsv10p1689.PMC3805923.pdf
"10       http://www.medsci.org  1702  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1702 -1714.  doi: 10.7150/ ijms.7114  Research Paper   Airway Administration of Vascular Endothelial Growth  Factor s iRNAs Induces Transient Airspace Enlargement  in Mice   Yusuke Takahashi1, Yotaro Izumi1, Mitsutomo Kohno1, Eiji Ikeda2, Hiroaki Nomori1  1.",Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
This is a n open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
10     http://www.medsci.org  1703  lature impairment.,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
"10     http://www.medsci.org  1704  (5’-GCUACAAGAUGAAGCGCCGGCUAA -3’), r e- spectively.",Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
"10     http://www.medsci.org  1705  staining was done with Mayer's hematoxyli n. For  each analysis, one section was randomly selected per  animal, and 5, 200 fold magnification fields were randomly selected per section.",Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
10     http://www.medsci.org  1706    Fig 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
10       http://www.medsci.org  1707  Air space enlargement on histology was quant i- fied by mean linear intercept.,OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
"10       http://www.medsci.org  1708  Western blot analysis for VEGF  Western blot analysis showed that the level of  VEGF protein expression in the lung  was signi ficantly  decreased in comparison to control at days 2 , 4, and 7   after VEGF siRNAs administration.",Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
10     http://www.medsci.org  1709        Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
10     http://www.medsci.org  1710,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
10     http://www.medsci.org  1711,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
10     http://www.medsci.org  1712    Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
"10       http://www.medsci.org  1713  Comment   VEGF  is a critical angiogenic factor in maintai n- ing normal tissue vasculature, endothelial cell growth,  and survival  [20].",Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
10     http://www.medsci.org  1714  ing [34].,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/ijmsv10p1702.PMC3805924.pdf
"10       http://www.medsci.org  1727  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1727 -1739.  doi: 10.7150/ ijms.6884  Research Paper   DNA Methylation Profiling Revealed Promoter       Hypermethylation -induced Silencing o f p16, DDAH2  and DUSP1 i n Primary Oral Squamous Cell Carcinoma   Goot Heah Khor1,2,3,8, Gabriele Ruth Anisah Froemming2, Rosnah Binti Zain3,4, Mannil  Thomas Abra- ham5, Effat  Omar2, Su Keng Tan6, Aik Choon Tan7, Vui King Vincent -Chong3,  and Kwai Lin Thong8,9  1.",Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
This is an ope n-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
10       http://www.medsci.org  1728  Introduction  Oral cancer is ranked sixth in the world’s list of  cancer deaths [1]  and estimation of 128 000 deaths  worldwide are due to oral cavity cancer in year of  2008 by the global burden of cancer (GLOBOCAN)  [2].,Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
"10     http://www.medsci.org  1729  methylation microarray analysis, and validated the  methylation status by MS -PCR and protein expression  by immunohistochemistry (IHC) assays.",OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
"10     http://www.medsci.org  1730  Table 1 : MS-PCR primers and conditions   Genes/   Conditions  P16 DDAH2  DUSP1   Methylated      a) Forward primer  5′TTATTAGAGGGTGGGGCGGATCGC3’  5'TTGGATTACGGTCGTGTC 3'  5'AGTTTGGAAAATTAAAGGAGC 3'   b) Reverse primer  5′GACCCCGAACCGCGCCGTAA 3′  5'ACGAAAACTAACCTTCCCG 3'  5'ATACCCACGTTACCTCCATA 3'   Unmethylated      a) Forward primer  5′TTATTAGAGGGTGGGGTGGATGT 3′  5'TTTTTGGATTATGGTTGTGTT 3'  5'GGAGTTTGGAAAATTAAAGGAGT 3'   b) Reverse primer  5′CAACCCCAAACCACAACCATA A 3′  5'ATACAAAAACTAACCTTCCCAC 3'  5'CAATACCCACATTACCTCCATA 3   Annealing  temperature (oC) 61 57 58  Product length (bp)    152 112  119  UCSC reference  location  chr9:21967751 -21994490  chr6:31695894 -31698245  chr5:172197482 -172199606       Immunohistochemical staining   Four micron -thickness of sections were depara f- fined, rehydrated and subjected to antigen retrieval  procedure prior to immunohistochemical (IHC) staining.",Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
"The list with significant methylated genes was generated using  one-way ANOVA with P < 0.05 and fold change > 2.0  [27],  which was then subjected to PANTHER (Protei n  ANalysis THrough Evolutionary Relationships) Cla s- sification System (http://www.pantherdb.",OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
"10     http://www.medsci.org  1731  variables  in SPSS software, version  17.0 ( SPSS , Ch i- cago, USA).",OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
10     http://www.medsci.org  1732  sis.,Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
10     http://www.medsci.org  1733    Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
10     http://www.medsci.org  1734    Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
"10     http://www.medsci.org  1735  study, the overall survival rate showed 38.1% for  OSCC patients (95% CI=27.1, 49.1) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
10       http://www.medsci.org  1736           Fig.,Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
10     http://www.medsci.org  1737  tive stress in normal cells .,Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
"10     http://www.medsci.org  1738  the Ministry of Higher Education, Malaysia.",Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
10     http://www.medsci.org  1739  54.,Non-OADS,/arxiv_data1/oa_pdf/5d/20/ijmsv10p1727.PMC3805925.pdf
"10       http://www.medsci.org  1746  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1746 -1754.  doi: 10.7150/ ijms.6887  Research Paper   Circulating Progenitor and Mature Endothelial Cells in  Deep Vein Thrombosis   Aline M Alessio1, Miriam P Beltrame3, Mariane C Flores Nascimento1, Cristina P Vicente2, Juliana AP de  Godoy2, Junia CR  Santos Silva2, Luis Fernando Bittar1, Irene Lorand -Metze1, Erich V de Paula1, Joyce M  Annichino -Bizzacchi1   1.",Non-OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
"10     http://www.medsci.org  1747  ferent panels have been proposed to characterize EPC,  no consensus has been reached about their precise phenotype.",Non-OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
"10     http://www.medsci.org  1748  at 37ºC for 1 hour, or overnight at 4ºC.",Non-OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
10     http://www.medsci.org  1749  CD 45 and CD 133.,Non-OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
"10       http://www.medsci.org  1750  During  standardization, 300.000 cells were ac- quired and the percentage of CEC and EPC were very  similar to results obtained during acquisition of 50,000  and 100,000 cells in mice and h umans samples, r e- spectively.",OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
"10     http://www.medsci.org  1751  were analyzed using the alternative panels, CEC and  EPC results were similar to those obtained on the standard panels, except for the fact that EPC peaked 48h after DVT induction, and remained significantly  higher until the 72 hour time -point (data not shown).",OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
"10       http://www.medsci.org  1752  Discussion   Hypercoagulability, alterations in blood flow  and endothelial injury/dysfunction have been recog- nized as key elements on the pathogenesis of DVT since 1856 [22].",Non-OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
"10     http://www.medsci.org  1753  notypes have been described, we obtained similar  results in mice and in DVT patients, supporting the biological relevance of our data, as well as the defin i- tion of CEC and EPC used in this study.",Non-OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
10     http://www.medsci.org  1754  bone marrow cells: a pilot study and a randomised controlled trial.,Non-OADS,/arxiv_data1/oa_pdf/be/8b/ijmsv10p1746.PMC3805926.pdf
"SUPPLEMENTARY MATERIAL  is linked to the online version of the paper at  http://www.nature.com/cpt ACKNOWLEDGMENTS This study was sponsored by Opsona Therapeutics, Republic of Ireland.",Non-OADS,/arxiv_data1/oa_pdf/03/4a/clpt2013150a.PMC3805945.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/3.0/ 600 VOLUME 94 NUMBER 5 | NOVEMBER  2013 | www.nature.com/cpt",Non-OADS,/arxiv_data1/oa_pdf/03/4a/clpt2013150a.PMC3805945.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/a1/srep03024.PMC3805968.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3024 | DOI: 10.1038/srep03024 5",Non-OADS,/arxiv_data1/oa_pdf/9f/a1/srep03024.PMC3805968.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Reprints and permissions information is available at http://www.nature.com/reprints Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/1a/srep03027.PMC3805969.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3027 | DOI: 10.1038/srep03027 6",Non-OADS,/arxiv_data1/oa_pdf/57/1a/srep03027.PMC3805969.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/da/06/srep03032.PMC3805970.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3032 | DOI: 10.1038/srep03032 6",Non-OADS,/arxiv_data1/oa_pdf/da/06/srep03032.PMC3805970.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3031 | DOI: 10.1038/srep03031 6",Non-OADS,/arxiv_data1/oa_pdf/b1/9b/srep03031.PMC3805971.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Dr. Sumioka and Dr. Ishiguro are employed by Advanced Telecommunications Research Institute International, which has patents on Hugvies.",OADS,/arxiv_data1/oa_pdf/ab/7e/srep03034.PMC3805974.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3034 | DOI: 10.1038/srep03034 6",Non-OADS,/arxiv_data1/oa_pdf/ab/7e/srep03034.PMC3805974.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3026 | DOI: 10.1038/srep03026 8",Non-OADS,/arxiv_data1/oa_pdf/ed/b2/srep03026.PMC3805975.pdf
"E-mail: ksungsoo@korea.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Public Health Res Perspect 2011 2(2), 83 e88 doi:10.1016/j.phrp.2011.07.004 pISSN 2210-9099 eISSN 2233-6052 ª2011, Korea Centers for Disease Control and Prevention.",Non-OADS,/arxiv_data1/oa_pdf/01/f8/main.PMC3805976.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: A patent has been filed on the technology but there are no financial arrangements beyond that.,Non-OADS,/arxiv_data1/oa_pdf/90/c6/srep03030.PMC3805977.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3030 | DOI: 10.1038/srep03030 9",Non-OADS,/arxiv_data1/oa_pdf/90/c6/srep03030.PMC3805977.pdf
"Organiza-tions that fund health research are acutely aware of the need  to ensure that their investments in knowledge creation dem- onstrate benefit and have defined KT as: a dynamic and it- erative process that includes synthesis, dissemination, ex-change, and ethically sound application of knowledge to improve the health…, provide more effective health services and products and strengthen the health care system (Cana- dian Institutes of Health Research; http://www.cihr- irsc.gc.ca/e/29418.html).",Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
A guidebook has been developed to create ques-tionnaires that measure beliefs and attitudes as behavior deter-minants (http://www.rebeqi.org/ViewFile.aspx?i temID=212).,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
A revised version of the model  with accompanying tools for implementation can serve as a  guide for KT (http://www.implementationscience.com/ con-tent/6/1/99/table/T4).,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
The Cochrane Effective Practice and Organisation of Care (EPOC) Group conducts extensive work systematically reviewing evidence support- ing KT and has grouped interventions in a framework  (http://whatiskt.wikispaces.com/EPOC+framework).,OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
An important source of  evidence on the effectiveness of KT interventions is the  EPOC group of the Cochrane Collaboration (http://www.epo c.cochrane.org).,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
The Cochrane collaboration  group that reviews KT research has published more than 70 systematic reviews (http://epoc.cochrane.org/) on this topic.,OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
Public awareness  campaigns  Informational bro- chures  Mass media* Targeted information about  gaps in meeting practice  standards  Networking Policy briefs  Legislative  action  Campaigns  Petitions  Health Forum and Dia- logue on Chronic Pain  http://www.mcmasterhea lthfo- rum.org/images/docs/eng ag- ing%20health%20system %20decision- mak- ers%20in%20supporting %20chronic%20pain%20 management_dialogue- summary_2011-06- 14.pdf Acquire evidence-based  knowledge   Tools/interventions de- signed to locate or access  health research or re- search-informed informa- tion; this includes push  out or dissemination of  evidence.,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
"Website with evi- dence-based informa- tion, or lay summaries  of new research stud- ies  Evidence resources such as  Evidence Updates  MacPlus (push out of  evidence):  http://plus.mcmaster.ca/ MacPLUSFS/Default.a spx?Page=1  Distribution of educa- tional materials*  Educational outreach * Local opinion leader* Evidence  resources for  policymakers      Evaluate/synthesize  evidence   Tools/interventions that  support or develop evi- dence synthesis – i.e.,  compile, appraise, or  synthesize the best re- search information on a  topic.",Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
"DISCERN— a tool for   the public to discrimi- nate between websites:   http://www.discern.or g.uk/   Tools/processes that pro- vide or synthesize informa-tion on etiology/prevalence,  diagnosis, treatment, prog- nosis, or outcome evalua- tion for clinicians, and/or  help clinicians identify the  quality of primary or syn- thesized evidence.",Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
"Neck pain CPG: http://www.jospt.org/issues/ arti- cleID.1454/article_detail.as p  Use of opioids:  http://nationalpaincentre.mc master.ca/opioid/ Tools/processes that provide or synthesize  information for policymakers, or help policymakers identify the quality of pri- mary or synthesize health policy evidence.",Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
Patient decision aid for  receiving neck manipu-lation for neck pain:  http://www.physio- pe- dia.com/Neck_Pain_Pat ient_Decision_Aid:_Ste p_6  Clinical prediction rule for  thoracic manipulation for neck pain.,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
"http://www.ispje.org/showcas es2009/PTJ.pdf  Local Consensus Process* Reminders*  Policy briefs  Policy-researcher    Adapt evidence to con- text  Tools/interventions de- signed to help users to  adapt research evidence or  evidence-informed infor- mation to make is relevant,  useful, or implementable  within a given context; this  includes assessment of  needs/barriers and modifi- cation of evidence to con- text.",Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
"PARiHS self assessment tool  Audit and feedback* http://www.implementationsc ience.com/content/6/1/99  PARiHS self assessment tool  Formal integration of services* Skill Mix Changes*     Implement specific ac- tions   (Implementation fidel- ity/scalability )  Tools/interventions that  focus on the operational  aspects of implement- ing/executing specific  actions that are defined by  best evidence; e.g., ensure  that implementation main- tains intervention fidelity,  scaling up from demonstra- tion project to widespread  use.",Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
Exercise toolkit: http://www.physio- pe- dia.com/Manual_Therapy_an d_Exercise_for_Neck_Pain:_ Clinical_Treatment_Tool- kit?title=Physiopedia:Copyrig hts  Structural interventions*    Facilitate the process of  change   Tools/interventions that  facilitate the general as- pects of change**.,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
This toolkit (http://www.physio-pedia.com/Neck_Pain_  Tool-kit:_Step_1) was produced in association with the In- ternational Collaboration on Neck overviews published in this issue.,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
Patient Perspec- tives (http://www.jospt.org/issues/perspectives.asp) summarize  individual research studies for lay audiences and may en-hance communication about research evidence with patients when making a shared decision about the treatment plan.,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
Strategies that have been studied by the Cochrane Effect ive Practice and Organization of Care group  throu gh publication  of systematic  reviews  are denoted  by * (http://epoc.cochrane.or g/our-reviews ).,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
(http://www.jospt.org/issues/perspectives.asp)     Clinical Practice Guidelines (CPGs)   Question  Answer   What is the inter- vention?,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
See Appraisal of Guidelines for Research and Evaluation (AGREE) collaboration (http://www.agreetrust.org/) and The  Guidelines International Network (http://www.g-i-n.net/).,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
(http://www.jospt.org/issues/articleID.,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
Use a guide to assist with development of a patient decision aid (http://decisionaid.ohri.ca/) or search for decision aids that  are already   developed; an online tutorial is also available.,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
(https://decisionaid.ohri.ca/ODST/)  The Cochrane Library also provides a decision aid Library (free login) (https://decisionaid.ohri.ca/DALI/) Follow quality criteria [52] for decision aids.,OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
An editorial on clinical prediction rules can be viewed at: http://jmmtonline.com/documents/v15n1/EditorialV15N1.pdf     Operational Manual or Tool   Question  Answer   What is the intervention?,Non-OADS,/arxiv_data1/oa_pdf/da/33/TOORTHJ-7-582.PMC3805983.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/2f/TODENTJ-7-109.PMC3805986.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bb/50/jcav04p0606.PMC3805988.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/56/3e/jcav04p0614.PMC3805989.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d6/bf/jcav04p0626.PMC3805990.pdf
This is an open- access article distributed under th e terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/49/1e/jcav04p0635.PMC3805991.pdf
Abrid ged life tables  for Japan 2006.  http://www.mhlw.go.jp/english/database/db -hw/   lifetb06/ index.html.,OADS,/arxiv_data1/oa_pdf/49/1e/jcav04p0635.PMC3805991.pdf
This is  an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/fb/jcav04p0644.PMC3805992.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d5/83/jcav04p0653.PMC3805993.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/f9/jcav04p0662.PMC3805994.pdf
Primers for both MSPCR and bisulfite PCR were  designed by web tools  MethPrimer  (http://www.urogene.org/cgi -bin/methprimer/met hprimer.cgi )  18.,OADS,/arxiv_data1/oa_pdf/16/f9/jcav04p0662.PMC3805994.pdf
This is consistent with a  UCHL1 expression at the GEO database showing that UCHL1 was reduced to no expression in the tissues from carboplatin resistant ovarian cancer patients (http://www.ncbi.nlm.nih.gov/geo/tools/profileGr aph.cgi?ID=GDS13 81:36990_at) compared to the car- boplatin sensitive tissues (Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/f9/jcav04p0662.PMC3805994.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/a9/jcav04p0671.PMC3805995.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6e/64/jcav04p0679.PMC3805996.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/41/7c/jcav04p0686.PMC3805997.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/e6/ceor-5-545.PMC3806112.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2013:5 545–553ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  545ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S5144 6Budget impact analysis of conversion from   cyclosporine to sirolimus as immunosuppressive   medication in renal transplantation therapy naghmeh Foroutan1 hamid R Rasekh1 Jamshid salamzadeh1 hamid R Jamshidi1 Mohsen nafar2 1Department of Pharmacoeconomics  and Pharmaceutical Management,   school of Pharmacy, shahid  Beheshti University of Medical  sciences, 2Department of Kidney  Transplantation, Urinary nephrology  Research Center (U nRC), shahid  labbafinejad Medical Center, shahid  Beheshti University of Medical  sciences, T ehran, iran Correspondence: naghmeh Foroutan   sDa Bocconi school of Management,   Via Bocconi, 8, Milan 20136, italy   Tel +39 02 5836 6875   Fax +39 02 5836 6890   Email nforoutan88@gmail.co mObjectives:  The aim of this study was to determine budget impact of conversion from  cyclosporine (CsA) to sirolimus (SRL) in renal transplant therapy (RTT) from the perspective  of insurance organizations in Iran.",Non-OADS,/arxiv_data1/oa_pdf/cf/e6/ceor-5-545.PMC3806112.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/cf/e6/ceor-5-545.PMC3806112.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/e6/ceor-5-545.PMC3806112.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/e1/lra-6-031.PMC3806121.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpLocal and Regional Anesthesia 2013:6 31–33Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  31CAse Repo Rtopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/LRA.S4958 0Unusual case of contralateral Horner’s   syndrome following stellate-ganglion block:   a case report and review of the literature Hassan H Amhaz1 Larry Manders2 elie J Chidiac1 Vinay pallekonda1 shushovan Chakrabortty1 1Department of Anesthesiology,   Detroit Medical Center, Detroit,    MI, UsA; 2Wayne state University   school of Medicine, Detroit, MI, UsA Correspondence: shushovan  Chakrabortty   Detroit Medical Center, 3990 John R   street – Room 2901, 2 Hudson,   Detroit, MI 48201, UsA   tel +1 313 966 3731   Fax +1 313 993 3889   email shuchakrausa@yahoo.co mAbstract:  Stellate-ganglion block (SGB) is a commonly performed procedure for the treat - ment of numerous conditions, including upper-extremity complex regional pain syndromes and  arterial insufficiency.",Non-OADS,/arxiv_data1/oa_pdf/20/e1/lra-6-031.PMC3806121.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/20/e1/lra-6-031.PMC3806121.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/e1/lra-6-031.PMC3806121.pdf
Available from: http://www.frca.co.uk/article.,Non-OADS,/arxiv_data1/oa_pdf/20/e1/lra-6-031.PMC3806121.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN SETBP1 mutations in 415 patients with primary myeloﬁbrosis or chronic myelomonocytic leukemia: independent prognostic impactin CMML Leukemia (2013) 27, 2100–2102; doi:10.1038/leu.2013.97 SETBP1 encodes SET-binding protein 1, a binding partner for the multi-function SET protein.",Non-OADS,/arxiv_data1/oa_pdf/e0/49/leu201397a.PMC3806243.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial Leukemia (2013) 27,2102–2105; doi:10.1038/leu.2013.110 Post-transplant lymphoproliferative disorder (PTLD) is a spectrum of lymphatic diseases associated with the use of potent immunosuppressive drugs after transplantation and ranges from polyclonal early lesions associated with primary Epstein-Barr virus(EBV) infection to monomorphic lymphoma.1The PTLD-1 trial, the largest prospective phase II trial in the ﬁeld so far, has demonstrated the efﬁcacy and safety of sequential therapy (rituximab followed by cyclophosphamide, doxorubicin,vincristin, prednisolone (CHOP) chemotherapy) with an overall response rate (ORR) of 90% and 6.6 years median overall survival (OS) in CD20-positive PTLD unresponsive to reduction ofimmunosuppression.",Non-OADS,/arxiv_data1/oa_pdf/e0/49/leu201397a.PMC3806243.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of theGruppo Italiano Trapianto Di Midollo Osseo Leukemia (2013) 27,2086–2091; doi:10.1038/leu.2013.208 The prognosis of acute myeloid leukemia (AML) patients under- going allogeneic hematopoietic stem cell transplantation (HSCT) not in complete remission is poor,1–3although this treatment option remains the only possible curative approach for thesepatients.4A retrospective analysis recently published by European Group for Blood and Marrow Transplantation (EBMT) on primary refractory AML allotransplanted with unrelated donors showedthat factors associated with improved survival were the following:having received fewer than three courses of induction therapy, the presence of a lower percentage of bone marrow blast inﬁltration at transplant and patient cytomegalovirusseropositivity.",Non-OADS,/arxiv_data1/oa_pdf/cb/0b/leu2013208a.PMC3806246.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparisonwith indolent mastocytosis Leukemia (2013) 27,2091–2094; doi:10.1038/leu.2013.227 Mastocytosis results from a clonal proliferation of morphological and immunophenotypically abnormal mast cells.1–4Extracuta- neous involvement is commonly seen in adults, and the diagnosis of systemic mastocytosis (SM) is established as per World HealthOrganization (WHO) criteria.5Patients are frequently referred with episodic symptoms of ‘mast cell activation’ (MCA), wherein an underlying allergic or autoimmune disorder cannot beidentiﬁed.6,7In the absence of cutaneous involvement by masto- cytosis, the next step typically is to determine whether SM is present.",Non-OADS,/arxiv_data1/oa_pdf/cb/0b/leu2013208a.PMC3806246.pdf
"Joyce Y. Tung1, Amy K. Kiefer1, Meghan Mullins1, Uta Francke1and Nicholas Eriksson1 123andMe Inc., Mountain View, California, USAE-mail: joyce@23andme.com SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Akagawa H, Tajima A, Sakamoto Y et al.",Non-OADS,/arxiv_data1/oa_pdf/3b/e8/jid2013196a.PMC3806248.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Six Mutations in AAGAB Conﬁrm its Pathogenic Role in Chinese Punctate Palmoplantar Keratoderma Patients Journal of Investigative Dermatology (2013) 133, 2631–2634; doi:10.1038/jid.2013.198; published online 13 June 2013 TO THE EDITOR Palmoplantar keratodermas (PPKs) are agroup of rare keratinization disorderscharacterized by the excessive forma-tion of keratin on the palms and soles.Four clinical types of PPK can be classi-ﬁed by the pattern of lesions: diffuse,punctuate, focal, and striate (Stevenset al.",Non-OADS,/arxiv_data1/oa_pdf/3b/e8/jid2013196a.PMC3806248.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Establishing optimal qPCR assays for JAK2 -V617F JV Jovanovic et al 2039 &2013 Macmillan Publishers Limited Leukemia (2013) 2032 – 2039",Non-OADS,/arxiv_data1/oa_pdf/f7/0c/leu2013219a.PMC3806250.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Desiccation/resuscitation cycle of M. vaginatus L Rajeev et al 2191 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/eb/5b/ismej201383a.PMC3806265.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Th e ISME Journal website (http://www.nature.com/ismej)Light-stimulated growth of Psychroflexus torquis S Feng et al 2213 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/1c/41/ismej201397a.PMC3806269.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/08/hft099.PMC3806282.pdf
http://clinicaltrials.gov/ct2/show/NCT01394562 (9 September 2012).,Non-OADS,/arxiv_data1/oa_pdf/f9/08/hft099.PMC3806282.pdf
http://clinicaltrials.gov/ct2/ show/NCT01453608?term=conﬁrm-hf&rank=1 (9 September 2012).G.,OADS,/arxiv_data1/oa_pdf/f9/08/hft099.PMC3806282.pdf
"To view a copy of this license, visit http://creative commons.org/licenses/by-nc-nd/3.0/ The Supplementary Information that accompanies this paper is available on the Immunology and Cell Biology website (http://www.nature.com/icb)AhR contribution to the differentiation of DC CFA Vogel et al 575 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/f2/f6/icb201343a.PMC3806313.pdf
http://dx.doi.org/10.1016/j.gpb.2013.05.005,OADS,/arxiv_data1/oa_pdf/b8/3e/main.PMC3806329.pdf
All iTRAQ results were uploaded into the Yale pro- tein expression database (YPED; http://yped.med.yale.edu/ repository/ )[54].,OADS,/arxiv_data1/oa_pdf/b8/3e/main.PMC3806329.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.gpb.2013.",OADS,/arxiv_data1/oa_pdf/b8/3e/main.PMC3806329.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)Metabolic engineering in cancer V Fritz et al 5110 Oncogene (2013) 5101 – 5110 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/7e/5e/onc2012523a.PMC3806338.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9e/fa/ncomms3453.PMC3806347.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Kun, A ´.",Non-OADS,/arxiv_data1/oa_pdf/9e/fa/ncomms3453.PMC3806347.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3453 8 NATURE COMMUNICATIONS | 4:2453 | DOI: 10.1038/ncomms3453 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9e/fa/ncomms3453.PMC3806347.pdf
"& Shennan, S. J. Spatial and Chronological Patterns in the Neolithisation of Europe, http://www.archaeologydataservice.ac.uk/archives/ view/c14_meso/ (2003).",Non-OADS,/arxiv_data1/oa_pdf/24/bd/ncomms3486.PMC3806351.pdf
"Central European database of14C dates for the Neolithic and Early Bronze Age, University of Kiel, Available at http://www.radon.ufg.uni-kiel.de (2012).",Non-OADS,/arxiv_data1/oa_pdf/24/bd/ncomms3486.PMC3806351.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/24/bd/ncomms3486.PMC3806351.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Shennan, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/24/bd/ncomms3486.PMC3806351.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3486 8 NATURE COMMUNICATIONS | 4:2486 | DOI: 10.1038/ncomms3486 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/24/bd/ncomms3486.PMC3806351.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsCompeting ﬁnancial interests: J.M.G.,Non-OADS,/arxiv_data1/oa_pdf/5a/9a/ncomms3564.PMC3806366.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Vaiyapuri, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/5a/9a/ncomms3564.PMC3806366.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3564 ARTICLE NATURE COMMUNICATIONS | 4:2564 | DOI: 10.1038/ncomms3564 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/5a/9a/ncomms3564.PMC3806366.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cancer Gene Therapy website (http://www.nature.com/cgt)Low CTL frequency after intrahepatic immunization N Obeng-Adjei et al 563 &2013 Nature America, Inc. Cancer Gene Therapy (2013), 552 – 563",Non-OADS,/arxiv_data1/oa_pdf/0f/96/cgt201352a.PMC3806376.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsCompeting ﬁnancial interests: R.K.J.,Non-OADS,/arxiv_data1/oa_pdf/e9/c0/ncomms3516.PMC3806395.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Chauhan, V.P.",Non-OADS,/arxiv_data1/oa_pdf/e9/c0/ncomms3516.PMC3806395.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3516 ARTICLE NATURE COMMUNICATIONS | 4:2516 | DOI: 10.1038/ncomms3516 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/e9/c0/ncomms3516.PMC3806395.pdf
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/miACKNOWLEDGEMENTS We thank Professor Clare Lloyd and Professor Leo Lefrancois for providing the GL3 anti- gdTCR hybridoma and Dr Rebecca Beavil at the MRC Asthma UK Center in Allergic Mechanisms of Asthma for antibody purification.,Non-OADS,/arxiv_data1/oa_pdf/d7/4e/mi20133a.PMC3806405.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/fa/62/ncomms3548.PMC3806408.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lim, H. E. et al.",Non-OADS,/arxiv_data1/oa_pdf/fa/62/ncomms3548.PMC3806408.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3548 ARTICLE NATURE COMMUNICATIONS | 4:2548 | DOI: 10.1038/ncomms3548 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/fa/62/ncomms3548.PMC3806408.pdf
http://dx.doi.org/ 10.1016/j.elspec.2013.03.008 (2013).NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3568 ARTICLE NATURE COMMUNICATIONS | 4:2568 | DOI: 10.1038/ncomms3568 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/38/31/ncomms3568.PMC3806410.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/31/ncomms3568.PMC3806410.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Liu, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/38/31/ncomms3568.PMC3806410.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3568 8 NATURE COMMUNICATIONS | 4:2568 | DOI: 10.1038/ncomms3568 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/38/31/ncomms3568.PMC3806410.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f5/8c/ncomms3527.PMC3806433.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ding, D.-S. et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/8c/ncomms3527.PMC3806433.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3527 ARTICLE NATURE COMMUNICATIONS | 4:2527 | DOI: 10.1038/ncomms3527 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f5/8c/ncomms3527.PMC3806433.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/CTL inactivation by immunosuppressive tolerogenic TIDCs HH a r i m o t o et al 555 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/e7/72/icb201338a.PMC3806489.pdf
Unaligned (non-human) reads were extracted using bam2fastq (http://www.hudsonalpha.org/gsl/information/software/bam2fastq) and further ﬁltered of human content using Bowtie40.,OADS,/arxiv_data1/oa_pdf/a4/02/ncomms3513.PMC3806554.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/02/ncomms3513.PMC3806554.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tang, K.-W. et al.",Non-OADS,/arxiv_data1/oa_pdf/a4/02/ncomms3513.PMC3806554.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3513 ARTICLE NATURE COMMUNICATIONS | 4:2513 | DOI: 10.1038/ncomms3513 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a4/02/ncomms3513.PMC3806554.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc- sa/3.0/GMS histological ﬁndings in primary open-angle glaucoma MR ˛ekas et al 1217 Eye",Non-OADS,/arxiv_data1/oa_pdf/98/cc/eye2013154a.PMC3806560.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/4f/jet095.PMC3806581.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/1a/9c/3747.PMC3806586.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3c/cc/3666.PMC3806587.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/67/4e/3775.PMC3806588.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f5/3c/3727.PMC3806589.pdf
(Bioinformatic analysis was based on genome-wide epigenetic data from the National Center for Biotechnology Information: http://www.ncbi.nlm.nih.gov/epigenomics.,OADS,/arxiv_data1/oa_pdf/f5/3c/3727.PMC3806589.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/dc/f6/3677.PMC3806590.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/bf/2e/3671.PMC3806591.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a8/67/3751.PMC3806592.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/1f/43/3661.PMC3806593.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8c/83/3863.PMC3806594.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b2/af/3658.PMC3806595.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/44/c1/3920.PMC3806596.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/aa/6d/3785.PMC3806597.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3d/cf/3647.PMC3806598.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f8/5a/3851.PMC3806599.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/98/a8/3909.PMC3806600.pdf
See  http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.DIGESTS,Non-OADS,/arxiv_data1/oa_pdf/8c/13/3958.PMC3806601.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/cb/b2/3797.PMC3806602.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0a/68/3718.PMC3806603.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/fb/38/3674.PMC3806604.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3a/e2/3709.PMC3806605.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4e/9b/3663.PMC3806606.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c6/be/3887.PMC3806607.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ef/62/3901.PMC3806608.pdf
Available from: http://www.endotext.org/diabetes/diabetes17/ diabetesframe17.htm Accessed 5 November 2012 18.,Non-OADS,/arxiv_data1/oa_pdf/ef/62/3901.PMC3806608.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/21/e9/3645.PMC3806609.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e1/64/3669.PMC3806610.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/34/f5/3951.PMC3806611.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/49/d3/3828.PMC3806612.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d2/ca/3687.PMC3806613.pdf
ACKNOWLEDGMENTS This work has been supported with funds from theGerman Ministry for Education and Research to the German Centre for Diabetes Research (http://www.dzd-ev .de) and the European Community ’s Seventh Framework Programme (FP7/2007-2013) for the Innovative Medicine Ini- tiative under grant agreement no.,Non-OADS,/arxiv_data1/oa_pdf/d2/ca/3687.PMC3806613.pdf
115005 (http://www.imidia .org).,Non-OADS,/arxiv_data1/oa_pdf/d2/ca/3687.PMC3806613.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/79/88/3927.PMC3806614.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/fe/48/3697.PMC3806615.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/81/8f/3807.PMC3806616.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/41/d4/3839.PMC3806617.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3e/f3/3766.PMC3806618.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/84/12/3736.PMC3806619.pdf
"Reads passing the Illumina “chastity ﬁlter”were aligned to the UCSC hg19 genome assembly (pseudoautosomal region on Y chromosome masked, alter- native haplotypes removed) using Novoalign v2.07.18 (http://www.novocraft .com), and duplicate read pairs were removed.",OADS,/arxiv_data1/oa_pdf/f3/6c/3943.PMC3806620.pdf
"Allele frequencies for each variant were estimated based on phase 1 genotypes from the 1000 Genomes project (8), the European Ameri-cans among the 6,500-exome release of the National Heart, Lung, and BloodInstitute (NHLBI) GO Exome Sequencing Project (http://evs.gs.washington.edu/EVS/), and the Finnish whole-exome data from the T2D-GENES (Type 2Diabetes Genetic Exploration by Next-generation sequencing in multi-EthnicSamples) consortium.",OADS,/arxiv_data1/oa_pdf/f3/6c/3943.PMC3806620.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f3/6c/3943.PMC3806620.pdf
*Relative densitometry measurements (WFS1/ tubulin) made with ImageJ64 (http://imagej.nih.gov/ij).L.L.,OADS,/arxiv_data1/oa_pdf/f3/6c/3943.PMC3806620.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2f/c3/3817.PMC3806621.pdf
"Podocytes were treated with 4% of the pooled sera (four C, four DKD2, and four DKD+pools) for 24 h. More detailed protocol information and results are available at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46900.",OADS,/arxiv_data1/oa_pdf/2f/c3/3817.PMC3806621.pdf
Microarray data are available at http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/2f/c3/3817.PMC3806621.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/52/f0/3656.PMC3806623.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0f/c9/3874.PMC3806624.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8b/cb/3936.PMC3806625.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ca/f6/3760.PMC3806626.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d6/0b/3205.PMC3806656.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/53/d9/3187.PMC3806657.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4f/80/3177.PMC3806658.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/91/75/3251.PMC3806659.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0e/8a/3238.PMC3806661.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/65/e3/3155.PMC3806662.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/52/e3/3164.PMC3806663.pdf
Determination of the percent splicing index The RNA samples were analyzed by the RNomics platform of Sher - brooke University (http://lgfus.ca/public/fr/node/22).,OADS,/arxiv_data1/oa_pdf/52/e3/3164.PMC3806663.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 645 Korean J Urol 2013;54:645-650www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.645 Review Article Role of the Epithelial-Mesenchymal Transition in Bladder Cancer:  From Prognosis to Therapeutic Target Seok Joong Yun, Wun-Jae Kim Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea Bladder cancer (BC) is the second most common malignancy of urological organs.",Non-OADS,/arxiv_data1/oa_pdf/20/c4/kju-54-645.PMC3806986.pdf
"Keywords:  Epithelial-mesenchymal transition; Pr ognosis; Urinary bladder neoplasms  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 July, 2013 accepted 2 August, 2013 Corresponding Author: Wun-Jae Kim  Department of Urology, Chungbuk National University  College of Medicine, 62  Kaeshin-dong, Heungduk-gu, Cheongju 361-711, Korea  TEL: +82-43-269-6371 FAX: +82-43-269-6144E-mail: wjkim@chungbuk.ac.kr INTRODUCTION Bladder cancer (BC) is responsi ble for the deaths of 150,000  people annually and is the seve nth most prevalent type of  cancer worldwide [1,2].",Non-OADS,/arxiv_data1/oa_pdf/20/c4/kju-54-645.PMC3806986.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 651 Korean J Urol 2013;54:651-659www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.651 Review Article Management of Complications After Tension-Free Midurethral  Slings Bülent Çetinel, Tufan Tarcan1 Department of Urology, Istanbul University Cerrahpa şa Medical School, Istanbul, 1Department of Urology, Marmara University School  of Medicine, Istanbul, Turkey Since their introduction in 1996, tension-fr ee midurethral slings (MUS) have been pro- ven to have long-term efficacy and safety.",Non-OADS,/arxiv_data1/oa_pdf/f9/5b/kju-54-651.PMC3806987.pdf
"Keywords:  Complication; Midurethral s ling; Stress urinary incontinence  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 July, 2013 accepted 16 August, 2013 Corresponding Author: Tufan Tarcan  Department of Urology, Marmara University School of Medicine,  Istanbul, Turkey TEL: +905434948365E-mail: tufan@marmara.edu.tr INTRODUCTION After the first clinical applic ation of the pubovaginal sling  a century ago, multiple types of  slings composed of different  materials, such as autografts , allografts, xenografts, and  synthetic material, have been tried for years with the hope of defining the ideal method of  suspension.",Non-OADS,/arxiv_data1/oa_pdf/f9/5b/kju-54-651.PMC3806987.pdf
Available from: http://www.fda.gov/MedicalDevices/Safety/ AlertsandNotices/PublicHea lthNotifications/ucm061976.htm.,Non-OADS,/arxiv_data1/oa_pdf/f9/5b/kju-54-651.PMC3806987.pdf
Available from: http://www.fda.gov/ MedicalDevices/Safety/AlertsandNotices/ucm262435.htm.,Non-OADS,/arxiv_data1/oa_pdf/f9/5b/kju-54-651.PMC3806987.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f9/5b/kju-54-651.PMC3806987.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 660 Korean J Urol 2013;54:660-665www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.660 Urological Oncology Experience of Ultrasonography-Guided Percutaneous Core Biopsy  for Renal Masses Seung Woo Lee, Min Ho Lee, Hee Jo Yang, Won Jae Yang1, Doo Sang Kim, Nam Kyu Lee,  Youn Soo Jeon  Department of Urology, Soonchunhyang University Cheonan Hospital, Cheonan, 1Soonchunhyang University Seoul Hospital, Seoul, Korea Purpose:  We evaluated the safety and accuracy  of ultrasonography-guided percuta- neous core biopsy collection in patients with renal masses.",Non-OADS,/arxiv_data1/oa_pdf/93/8b/kju-54-660.PMC3806988.pdf
"Keywords:  Fine-needle biopsy; Kidney This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 April, 2013 accepted 3 July, 2013 Corresponding Author: Youn Soo JeonDepartment of Urology,  Soonchunhyang University  Cheonan Hospital, 31 Suncheonhyang 6-gil,  Dongnam-gu, Cheonan 330-930,  KoreaTEL: +82-41-570-2275, 2875 FAX: +82-41-574-6248 E-mail: ysurol@schmc.ac.kr INTRODUCTION Traditionally, most solid re nal masses have been managed  surgically with radical nephre ctomy.",Non-OADS,/arxiv_data1/oa_pdf/93/8b/kju-54-660.PMC3806988.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 666 Korean J Urol 2013;54:666-670www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.666 Urological Oncology Are Hypoechoic Lesions on Transrectal Ultrasonography a Marker  for Clinically Significant Prostate Cancer?",Non-OADS,/arxiv_data1/oa_pdf/91/9a/kju-54-666.PMC3806989.pdf
"Keywords:  Clinical marker; Prostate neoplasms; Ultrasonography  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 April, 2013 accepted 5 July, 2013 Corresponding Author: Jae Young Park Department of Urology, Korea University Ansan Hospital,  Korea University College of  Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 425-707,  Korea TEL: +82-31-412-6545FAX: +82-31-412-5194 E-mail: jaeyoungpark@korea.",Non-OADS,/arxiv_data1/oa_pdf/91/9a/kju-54-666.PMC3806989.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 671 Korean J Urol 2013;54:671-676www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.671 Urological Oncology Effect of Overexpression of Glucose-Regulated Protein 78 and Bcl-2  on Recurrence and Survival in Patients With Ureter Tumors Chang Hyun Park, Mi Sun Choi1, Ji Yong Ha2, Byung Hoon Kim, Choal Hee Park, Chun Il Kim Departments of Urology and 1Pathology, Keimyung University School of Medicine, Daegu, 2Department of Urology, Yonsei University  College of Medicine, Seoul, Korea Purpose:  The utility of the expression of gluc ose-regulated protein 78 (GRP78) in the  evaluation of prognosis depends on the type of tumor.",Non-OADS,/arxiv_data1/oa_pdf/06/10/kju-54-671.PMC3806990.pdf
"Keywords:  Bcl-2; GRP78; Urothelial cell carcinoma This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 4 June, 2013 accepted 3 July, 2013 Corresponding Author: Chun Il Kim Department of Urology,  Keimyung University Dongsan Medical Center, Keimyung  University School of Medicine, 56  Dalseong-ro, Jung-gu, Daegu 700-712, Korea  TEL: +82-53-250-7084 FAX: +82-53-250-7646E-mail: cikim@dsmc.or.kr INTRODUCTION Ureter tumors account for 5% of overall transitional cell  carcinoma cases [1].",Non-OADS,/arxiv_data1/oa_pdf/06/10/kju-54-671.PMC3806990.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 677 Korean J Urol 2013;54:677-681www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.677 New Technology/Lasers in Urology Twelve-Month Follow-up Results of Photoselective Vaporization of  the Prostate With a 980-nm Diode Laser for Treatment of Benign Hyperplasia Youngho Kim, Youl Keun Seong, In Gon Kim, Bo Hyun Han Department of Urology, Maryknoll Medical Center, Busan, Korea Purpose:  This study was conducted with the use of 12 months of follow-up data to eval- uate the efficacy of photoselective vaporization of the prostate (PVP) with the 980-nm  diode laser for the treatment of symptomatic benign prostatic hyperplasia (BPH).",Non-OADS,/arxiv_data1/oa_pdf/61/a0/kju-54-677.PMC3806991.pdf
"Keywords:  Benign prostatic hyperplasia;  Complications; K2 diode; Laser This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 18 March, 2013 accepted 23 July, 2013 Corresponding Author: Youl Keun Seong Department of Urology, Maryknoll Medical Center, 121  Junggu-ro, Jung-gu, Busan  600-730, KoreaTEL: +82-51-461-2569 FAX: +82-51-465-7475 E-mail: ggochis@hanmail.net INTRODUCTION  With the aging of society, the absolute number of patients  undergoing surgery after a diagnosis of benign prostatic hyperplasia (BPH) is on the rise, which may be associated with the increase in the absolute number of BPH patients [1].",Non-OADS,/arxiv_data1/oa_pdf/61/a0/kju-54-677.PMC3806991.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 682 Korean J Urol 2013;54:682-688www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.682 Voiding Dysfunction/Female Urology Effect of Transurethral Resection With Hydrodistention for the  Treatment of Ulcerative Interstitial Cystitis Eui Sang Lee, Sang Wook Lee, Kwang Woo Lee, Jun Mo Kim, Young Ho Kim, Min Eui Kim Department of Urology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea Purpose:  Many treatment options to help relieve the symptoms of interstitial cystitis  (IC) are available, but none are effective.",Non-OADS,/arxiv_data1/oa_pdf/14/83/kju-54-682.PMC3806992.pdf
"Keywords:  Interstitial cystitis ; Treatment outcome This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 28 May, 2013 accepted 9 August, 2013 Corresponding Author: Young Ho Kim Department of Urology, Soonchunhyang University  Bucheon Hospital,  Soonchunhyang University College of Medicine, 170  Jomaru-ro, Wonmi-gu, Bucheon  420-767, KoreaTEL: +82-32-621-5463 FAX: +82-32-621-5018 E-mail: yhkuro@Schmc.ac.kr INTRODUCTION Interstitial cystitis (IC) is a disease accompanied by void- ing symptoms such as increased frequency, nocturia, and urgency as well as pain in the bladder.",Non-OADS,/arxiv_data1/oa_pdf/14/83/kju-54-682.PMC3806992.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 689 Korean J Urol 2013;54:689-692www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.689 Endourology/Urolithiasis Efficacy of Percutaneous Nephrostomy During Flexible  Ureteroscopy for Renal Stone Management Se Yun Kwon, Bum Soo Kim, Hyun Tae Kim, Yoon Kyu Park Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea Purpose:  Preoperative percutaneous nephrostomy (PCN) can be applied to urinary  stone patients with pyelonephritis as well as  obstructive uropathy; thus, some patients  undergo flexible ureteroscopy (fURS) in th e presence of a PCN tube.",Non-OADS,/arxiv_data1/oa_pdf/41/88/kju-54-689.PMC3806993.pdf
"Keywords:  Kidney calculi; Percutane ous nephrostomy; Ureteroscopy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 March, 2013 accepted 3 July, 2013 Corresponding Author: Bum Soo Kim Department of Urology, Kyungpook National University  Hospital, Kyungpook National  University School of Medicine, 130 Dongdeok-ro, Jung-gu,  Daegu 700-721, Korea TEL: +82-53-200-5855FAX: +82-53-421-9618 E-mail: dock97@hanmail.net INTRODUCTION Since Marshall [1] first described the visualization of a ure- teral calculus with a 9-Fr flexible, passively deflectable ureteroscope in 1964, advances in distal-tip deflection and scope durability have expanded the role of flexible uretero- scopy (fURS) [2].",Non-OADS,/arxiv_data1/oa_pdf/41/88/kju-54-689.PMC3806993.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 693 Korean J Urol 2013;54:693-696www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.693 Endourology/Urolithiasis Is Tubeless Percutaneous Nephrolithotomy a Feasible Technique  for the Treatment of Staghorn Calculi?",Non-OADS,/arxiv_data1/oa_pdf/5a/fa/kju-54-693.PMC3806994.pdf
"Keywords:  Kidney calculi; Nephrolitho tomy; Percutaneous nephrostomy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 9 May, 2013 accepted 19 July, 2013 Corresponding Author: Jin Kyu OhDepartment of Urology, Gachon  University Gil Medical Center, 21  Namdong-daero 774beon-gil, Namdong-gu, Incheon 405-760,  Korea TEL: +82-32-460-8506FAX: +82-32-460-8340 E-mail: shaq21@empas.com INTRODUCTION Since the introduction of percutaneous nephrolithotomy  (PNL) for the treatment of renal calculi by Fernstrom and Johansson [1], rapid progress has been made in the devel-opment of techniques for PNL [2].",Non-OADS,/arxiv_data1/oa_pdf/5a/fa/kju-54-693.PMC3806994.pdf
Available from:  http://www.uroweb.org/gls/p df/Urolithiasis%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5a/fa/kju-54-693.PMC3806994.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 697 Korean J Urol 2013;54:697-702www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.697 Sexual Dysfunction/Male Infertility Effects of Low-Dose Tamsulosin on Sexual Function in Patients  With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia Sin Wook Kim, Wan Cheol Lee, Ma Tae Kim, Kyungtae Ko, Won Ki Lee, Choong-Hyun Lee1,  Je Jong Kim2, Dae Yul Yang Department of Urology, Hallym University College of Medicine, Chuncheon, 1Department of Urology, Kyung Hee University School of  Medicine, Seoul, 2Department of Urology, Korea University College of Medicine, Seoul, Korea Purpose:  The aim of the present study was to evaluate the effects of low-dose tamsulosin  on sexual function in patients with lowe r urinary tract symptoms (LUTS) suggestive  of benign prostatic hyperplasia.",Non-OADS,/arxiv_data1/oa_pdf/e7/20/kju-54-697.PMC3806995.pdf
"Keywords:  Ejaculation; Erectile dysfuncti on; Lower urinary tract symptoms;  Prostatic  hyperplasia; Tamsulosin This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 29 May, 2013 accepted 2 July, 2013 Corresponding Author: Dae Yul Yang Department of Urology, Hallym University Kangdong Sacred  Heart Hospital, Hallym  University College of Medicine, 150 Seongan-ro, Gangdong-gu,  Seoul 134-701, Korea  TEL: +82-2-2224-2291FAX: +82-2-2224-2769 E-mail: yang1408@hallym.or.kr INTRODUCTION Lower urinary tract symptoms (LUTS) are the most com- mon complaint in aging urolog ic patients.",Non-OADS,/arxiv_data1/oa_pdf/e7/20/kju-54-697.PMC3806995.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 703 Korean J Urol 2013;54:703-709www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.703 Sexual Dysfunction/Male Infertility Impact of Surgical Varicocele Repair on Pregnancy Rate in  Subfertile Men With Clinical Varicocele and Impaired Semen Quality: A Meta-Analysis of Randomized Clinical Trials Kyu Hyun Kim, Joo Yong Lee, Dong Hyuk Kang1, Hyungmin Lee2, Ju Tae Seo3, Kang Su Cho Department of Urology, Severance Hospital, Urological Scienc e Institute, Yonsei University College of Medicine, Seoul, 1Department of  Urology, National Forensic Hospital, Ministry of Justice, Gongju, 2Division of Epidemic Intelligence Service, Korea Centers for Disease  Control and Prevention, Cheongwon, 3Department of Urology, Cheil General Hospital & Women 's Healthcare Center, Kwandong University  College of Medicine, Seoul, Korea Purpose:  To elucidate the impact of surgical varicocele repair on the pregnancy rate  through new meta-analyses of ra ndomized clinical trials that  compared surgical varico- cele repair and observation.",Non-OADS,/arxiv_data1/oa_pdf/d8/13/kju-54-703.PMC3806996.pdf
"Keywords:  Infertility; Meta-analysis; T reatment outcome; Varicocele This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 June, 2013 accepted 10 July, 2013 Corresponding Author: Kang Su ChoDepartment of Urology,  Severance Hospital, Urological  Science Institute, Yonsei University College of Medicine,  50 Yonsei-ro, Seodaemun-gu,  Seoul 120-752, KoreaTEL: +82-2-2228-2320 FAX: +82-2-312-2538 E-mail: kscho99@yuhs.ac INTRODUCTION The most common cause of male infertility is varicocele,  which can be detected in at least 35% of infertile men and is generally correctable or at least treatable [1,2].",Non-OADS,/arxiv_data1/oa_pdf/d8/13/kju-54-703.PMC3806996.pdf
"2.15.3, R Foundation for Statistical Computing, Vienna, Austria; http://www.r-project.org).",Non-OADS,/arxiv_data1/oa_pdf/d8/13/kju-54-703.PMC3806996.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 710 Korean J Urol 2013;54:710-714www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.710 Pediatric/Reconstructive Urology Clinical Factors That Predict Successful Posterior Urethral  Anastomosis With a Gracilis Muscle Flap Jin Ho Hwang, Moon Hyung Kang, Young Tae Lee, Dong Soo Park, Seung Ryeol Lee Department of Urology, CHA Bundang Medical Center, CHA University, Seongnam, Korea Purpose:  We evaluated the preoperative clinical factors that affect the surgical outcome  of posterior urethral anastomosis (PUA) with a gracilis muscle flap  (GMF) to determine  which factors predict benefit from the use of the GMF.",Non-OADS,/arxiv_data1/oa_pdf/f7/3d/kju-54-710.PMC3806997.pdf
"Keywords:  Surgical anastomosis; Surgic al flap; Urethral stricture This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 April, 2013 accepted 31 July, 2013 Corresponding Author: Seung Ryeol Lee Department of Urology, CHA  Bundang Medical Center, CHA University, 59 Yatap-ro,  Bundang-gu, Seongnam 463-712,  KoreaTEL: +82-31-780-5350 FAX: +82-31-780-5323 E-mail: seung102@cha.ac.kr INTRODUCTION The golden triad for a successful outcome in posterior ure- thral anastomosis (PUA) has b een defined as complete ex- cision of scarred tissue, a lateral fixation of healthy ure-thral end mucosa, and the creation of a tension-free anasto-mosis [1,2].",Non-OADS,/arxiv_data1/oa_pdf/f7/3d/kju-54-710.PMC3806997.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 715 Korean J Urol 2013;54:715-717www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.715 Case Report Nephrectomy for a Renal Metastasis of Undiagnosed  Hepatocellular Carcinoma Arising From an Orthotopic Liver Transplant Undertaken for Cryptogenic Cirrhosis Kevin W K Ong1, Binoy Joseph1, Dennis V Gyomber1, Damien M Bolton1, Nathan Lawrentschuk1,2 1Department of Surgery (Urology), Austin Ho spital, University of Melbourne, Heidelberg, 2Ludwig Institute for Cancer Research, Austin  Hospital, Melbourne, Australia Urological involvement of hepatocellular ca rcinoma (HCC) is rare; HCC arising in an  orthotopic liver transplant (OLT) is exceptio nally rare.",Non-OADS,/arxiv_data1/oa_pdf/b5/17/kju-54-715.PMC3806998.pdf
"Keywords:  Kidney neoplasms; Liver neoplasms;  Liver transplant ation; Neoplasm  metastasis; Nephrectomy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 30 January, 2012 accepted 14 May, 2012 Corresponding Author: Nathan Lawrentschuk Department of Surgery (Urology),  Austin Hospital, University of  Melbourne, Suite 5, 210  Burgundy Street , Heidelberg  3084, Victoria, Australia TEL: +61394553363 FAX: +61394575829 E-mail: lawrents chuk@gmail.com INTRODUCTION Hepatocellular carcinoma (HCC) is one of the most com- mon malignancies globally and accounts for nearly 1 mil-lion new cases per year [1].",Non-OADS,/arxiv_data1/oa_pdf/b5/17/kju-54-715.PMC3806998.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 718 Korean J Urol 2013;54:718-720www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.10.718 Case Report Missed Spermatic Cord Torsion in an Old Man Yu Mi Seo, Na-Hye Myung1, Jeong Hee Hong Departments of Urology and 1Pathology, Dankook University College of Medicine, Cheonan, Korea The fate of testicular salvage in spermatic co rd torsion depends on the duration of ische- mia and the degree of torsion.",Non-OADS,/arxiv_data1/oa_pdf/bd/6d/kju-54-718.PMC3806999.pdf
"Keywords:  Age groups; Spermatic cord torsion; Testis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 July, 2011 accepted 29 August, 2011 Corresponding Author: Jeong Hee HongDepartment of Urology, Dankook  University College of Medicine,  119 Dandae-ro, Dongnam-gu, Cheonan 330-997, Korea TEL: +82-41-550-3944 FAX: +82-41-551-6630E-mail: hjh178@medimail.co.kr INTRODUCTION Spermatic cord torsion (SCT) is one of the true urological  emergencies that mainly deve lop during puberty and the  early adolescent period, with a calculated annual incidence  of 1 in 4,000 among those under 25 years old [1].",Non-OADS,/arxiv_data1/oa_pdf/bd/6d/kju-54-718.PMC3806999.pdf
"Although autophagy is mostly a non-Neuronal Autophagy and   Neurodevelopmental Disorders Kyung-Min Lee1, Su-Kyung Hwang2 and Jin-A Lee3* 1Department of Anatomy, Graduate School of Medicine, Kyungpook National University, 2Department of Pediatrics,  Kyungpook National University Hospital, Daegu 700-422, 3Department of Biological Science and Biotechnology,  College of Life Science and Nanotechnology, Hannam University, Dajeon 305-811, Korea http://dx.doi.org/10.5607/en.2013.22.3.133 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
"Key words:  m TOR, autophagy, neurodevelopment, homeostasis, neurodevelopmental disorders Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
"134 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Kyung-Min Lee, et al.",OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
135 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Autophagy in Neuronal Development and Neurodevelopmental Disorders independent autophagy pathways has been reported [9].,OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
"136 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Kyung-Min Lee, et al.",OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
137 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Autophagy in Neuronal Development and Neurodevelopmental Disorders with alteration of autophagy during neural development.,OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
"138 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Kyung-Min Lee, et al.",OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
"139 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Autophagy in Neuronal Development and Neurodevelopmental Disorders K.M.L was supported by the Basic Science Research Program  through the NRF funded by the Ministry of Science, ICT and  Future Planning (2013R1A1A3010216) and the National Honor  Scientist Program (2013-16200000, B.K.K.).",OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
"140 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Kyung-Min Lee, et al.",OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
141 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Autophagy in Neuronal Development and Neurodevelopmental Disorders 655.,Non-OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
"142 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.133Kyung-Min Lee, et al.",OADS,/arxiv_data1/oa_pdf/42/d0/en-22-133.PMC3807000.pdf
"EphA receptors bind to ephrin-As, which are tethered  to cell membrane through glycophosphatidylinositol (GPI) Brain-Region Specific Apoptosis Triggered   by Eph/ephrin Signaling Soochul Park * Department of Biological Science, Sookmyung Women’s University, Seoul 140-742, Koreahttp://dx.doi.org/10.5607/en.2013.22.3.143 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/35/05/en-22-143.PMC3807001.pdf
"Key words:  EphA, ephrin-A, apoptosis, early brain development Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/05/en-22-143.PMC3807001.pdf
144 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.143Soochul Park anchors.,Non-OADS,/arxiv_data1/oa_pdf/35/05/en-22-143.PMC3807001.pdf
145 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.143Brain-Region Specific Apoptosis the growth cone have the opposing effects of axon growth and  attraction.,Non-OADS,/arxiv_data1/oa_pdf/35/05/en-22-143.PMC3807001.pdf
146 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.143Soochul Park it is predicted that ephrinA5-Fc stimulates forward signaling  through EphA receptors when its expression is induced in cells  expressing both EphA7 and ephrin-A5.,Non-OADS,/arxiv_data1/oa_pdf/35/05/en-22-143.PMC3807001.pdf
"147 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.3.143Brain-Region Specific Apoptosis existing bi-directional Eph/ephrin signaling at sites of cell-cell  contact, the total signaling may be above a threshold for activation  of the pro-apoptotic pathway (Fig.",Non-OADS,/arxiv_data1/oa_pdf/35/05/en-22-143.PMC3807001.pdf
